| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 1.93e-10 | 17 | 205 | 7 | GO:0005132 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH10 MYH11 MYO1E MYO6 KIF15 KIF5A DNHD1 KIF21A MYH14 KIF4B DNAH11 | 3.75e-08 | 118 | 205 | 11 | GO:0003774 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | HAUS6 MYH10 MYH11 MYO1E MAP1B MYO6 CENPF SPTB SPTBN1 NF1 BRCA1 KIF15 FMN1 TLN2 KIF5A FERMT2 CAMSAP2 NOS2 ANK3 DCTN2 IFT74 KIF21A TOM1 BAG2 KLC2 SPAG5 CCDC88A MYH14 SIPA1L1 KIF4B TNNI2 | 2.99e-07 | 1099 | 205 | 31 | GO:0008092 |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 1.05e-05 | 5 | 205 | 3 | GO:0050649 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 4.14e-05 | 38 | 205 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 5.75e-05 | 8 | 205 | 3 | GO:0101021 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.26e-05 | 70 | 205 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | microtubule binding | HAUS6 MAP1B CENPF NF1 KIF15 FMN1 KIF5A CAMSAP2 KIF21A SPAG5 CCDC88A KIF4B | 8.58e-05 | 308 | 205 | 12 | GO:0008017 |
| GeneOntologyMolecularFunction | actin filament binding | MYH10 MYH11 MYO1E MYO6 SPTB SPTBN1 TLN2 FERMT2 MYH14 SIPA1L1 | 1.24e-04 | 227 | 205 | 10 | GO:0051015 |
| GeneOntologyMolecularFunction | actin binding | MYH10 MYH11 MYO1E MAP1B MYO6 SPTB SPTBN1 FMN1 TLN2 FERMT2 NOS2 CCDC88A MYH14 SIPA1L1 TNNI2 | 1.35e-04 | 479 | 205 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | cytokine receptor binding | TGFBRAP1 FERMT2 ANGPT2 IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 MADD IFNA17 IFNA21 CCDC88A | 1.38e-04 | 324 | 205 | 12 | GO:0005126 |
| GeneOntologyMolecularFunction | tubulin binding | HAUS6 MAP1B CENPF NF1 BRCA1 KIF15 FMN1 KIF5A CAMSAP2 IFT74 KIF21A SPAG5 CCDC88A KIF4B | 1.44e-04 | 428 | 205 | 14 | GO:0015631 |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.66e-04 | 11 | 205 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.82e-04 | 28 | 205 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH10 MYH11 MYO1E MYO6 ABCA13 KIF15 KIF5A DNHD1 IPO8 KIF21A DHX57 ORC4 MLH3 MYH14 DDX25 KIF4B DNAH11 | 2.11e-04 | 614 | 205 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 3.57e-04 | 14 | 205 | 3 | GO:0008401 | |
| GeneOntologyMolecularFunction | aromatase activity | 4.40e-04 | 35 | 205 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 6.21e-04 | 4 | 205 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | calmodulin binding | 6.40e-04 | 230 | 205 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 1.03e-03 | 5 | 205 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 1.03e-03 | 5 | 205 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 1.53e-03 | 6 | 205 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 1.53e-03 | 6 | 205 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.59e-03 | 49 | 205 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 1.62e-03 | 23 | 205 | 3 | GO:0030215 | |
| GeneOntologyMolecularFunction | phospholipid binding | RAPGEF6 MYO1E MAP1B SPTBN1 ATG2A ITPR3 NF1 PLA2G4A FERMT2 PCLO TOM1 APOA4 CCDC88A EXOC1 | 1.64e-03 | 548 | 205 | 14 | GO:0005543 |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 2.13e-03 | 7 | 205 | 2 | GO:0070643 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 8.93e-10 | 21 | 205 | 7 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 2.59e-09 | 24 | 205 | 7 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 8.58e-09 | 28 | 205 | 7 | GO:0042501 | |
| GeneOntologyBiologicalProcess | microtubule-based process | HAUS6 SLK MAP1B BBS1 CNTLN LYST FSIP2 CEP120 BRCA1 KIF15 KIF5A CAMSAP2 ZMYND12 BBOF1 DNHD1 ANK3 DCTN2 IFT74 KIF21A KLC2 MEI1 HAUS2 MADD SPAG5 WDR19 CCDC88A AKAP9 CCDC42 TXNDC9 KIF4B DNAH11 | 6.36e-08 | 1058 | 205 | 31 | GO:0007017 |
| GeneOntologyBiologicalProcess | cytokinesis | MYH10 SPTBN1 EXOC3 BIRC6 PIK3R4 TAS2R13 ANK3 MEI1 CEP55 ORC4 KIF4B EXOC1 EXOC2 | 1.38e-07 | 204 | 205 | 13 | GO:0000910 |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 1.74e-07 | 42 | 205 | 7 | GO:0002323 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | LYST STAT5A STAT5B IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 | 4.61e-07 | 124 | 205 | 10 | GO:0030101 |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent cytokinesis | 5.75e-07 | 127 | 205 | 10 | GO:0061640 | |
| GeneOntologyBiologicalProcess | organelle assembly | SNF8 BRIX1 HAUS6 MYH10 MYH11 CENPF BBS1 ATG2A SIX4 DOCK5 FSIP2 CEP120 BRCA1 KIF15 SCLT1 ZMYND12 BBOF1 DNHD1 TRAF7 LRFN1 IFT74 TOM1 RILPL1 HAUS2 SPAG5 WDR19 CCDC88A CCDC42 SIPA1L1 KIF4B | 9.97e-07 | 1138 | 205 | 30 | GO:0070925 |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 1.17e-06 | 55 | 205 | 7 | GO:0043330 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 1.80e-06 | 112 | 205 | 9 | GO:0140888 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 2.08e-06 | 85 | 205 | 8 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 2.27e-06 | 86 | 205 | 8 | GO:0071357 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 2.99e-06 | 63 | 205 | 7 | GO:0043331 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | HAUS6 SLK MAP1B BBS1 CNTLN FSIP2 CEP120 BRCA1 KIF15 CAMSAP2 ZMYND12 BBOF1 ANK3 DCTN2 MEI1 HAUS2 SPAG5 CCDC88A AKAP9 CCDC42 TXNDC9 KIF4B | 3.15e-06 | 720 | 205 | 22 | GO:0000226 |
| GeneOntologyBiologicalProcess | response to type I interferon | 3.78e-06 | 92 | 205 | 8 | GO:0034340 | |
| GeneOntologyBiologicalProcess | mitotic cytokinesis | 4.82e-06 | 95 | 205 | 8 | GO:0000281 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 7.61e-06 | 101 | 205 | 8 | GO:0033138 | |
| GeneOntologyBiologicalProcess | intracellular transport | SNF8 MYH10 CLTCL1 MAP1B MYO6 VPS13C BBS1 LYST PIK3R4 CDAN1 STX5 NF1 CEP120 BRCA1 TGFBRAP1 KIF5A DOP1B CCHCR1 IPO8 ANK3 COG7 IFT74 RBM4 TOM1 KLC2 RILPL1 MED1 MADD SPAG5 WDR19 RANBP17 CCDC88A DDX25 | 1.26e-05 | 1496 | 205 | 33 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of Golgi organization | 2.60e-05 | 18 | 205 | 4 | GO:1903358 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | STAT4 STAT5A STAT5B IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 | 3.03e-05 | 198 | 205 | 10 | GO:0007259 |
| GeneOntologyBiologicalProcess | cellular response to virus | 3.22e-05 | 90 | 205 | 7 | GO:0098586 | |
| GeneOntologyBiologicalProcess | ventricular system development | 3.55e-05 | 38 | 205 | 5 | GO:0021591 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | MAP1B BBS1 FSIP2 KIF15 KIF5A ZMYND12 BBOF1 DNHD1 ANK3 IFT74 KIF21A KLC2 MADD WDR19 KIF4B DNAH11 | 3.61e-05 | 493 | 205 | 16 | GO:0007018 |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 3.80e-05 | 63 | 205 | 6 | GO:0050691 | |
| GeneOntologyBiologicalProcess | cell cycle process | PDS5B SYCP2L HAUS6 MYH10 CENPF SPTBN1 EXOC3 CNTLN BIRC6 FANCA PIK3R4 TAS2R13 CEP120 BRCA1 KIF15 NIPBL ANK3 DCTN2 USP29 MED1 MEI1 HAUS2 SPAG5 CEP55 ORC4 MLH3 CCDC42 SMARCC2 KIF4B EXOC1 EXOC2 | 3.86e-05 | 1441 | 205 | 31 | GO:0022402 |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | STAT4 STAT5A STAT5B IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 | 6.32e-05 | 216 | 205 | 10 | GO:0097696 |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 6.94e-05 | 137 | 205 | 8 | GO:0033135 | |
| GeneOntologyBiologicalProcess | vesicle tethering involved in exocytosis | 7.78e-05 | 9 | 205 | 3 | GO:0090522 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 7.78e-05 | 9 | 205 | 3 | GO:0002933 | |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 1.10e-04 | 10 | 205 | 3 | GO:0046543 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 1.19e-04 | 148 | 205 | 8 | GO:0002286 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 1.89e-04 | 201 | 205 | 9 | GO:0030183 | |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 1.89e-04 | 119 | 205 | 7 | GO:0006892 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 1.99e-04 | 12 | 205 | 3 | GO:0070989 | |
| GeneOntologyBiologicalProcess | cell division | PDS5B HAUS6 MYH10 CENPF SPTBN1 EXOC3 BIRC6 PIK3R4 TAS2R13 ANK3 MEI1 HAUS2 SPAG5 CEP55 ORC4 KIF4B EXOC1 EXOC2 | 2.18e-04 | 697 | 205 | 18 | GO:0051301 |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | HIPK1 PYDC2 STAT4 STAT5A STAT5B USP29 CASP5 MED1 IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 IL1RL1 | 2.23e-04 | 577 | 205 | 16 | GO:0019221 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | HAUS6 SLK MYH10 MYH11 MYO1E MAP1B MYO6 SPTB SPTBN1 PFDN1 SIX4 NF1 CEP120 AEBP1 FMN1 FERMT2 CAMSAP2 CASP5 SEMA5A HAUS2 CCDC88A AKAP9 | 2.27e-04 | 957 | 205 | 22 | GO:0097435 |
| GeneOntologyBiologicalProcess | organelle localization | SNF8 MYH10 MAP1B CENPF EXOC3 STX5 CEP120 KIF5A DCTN2 PCLO KLC2 MEI1 MADD SPAG5 CEP55 AKAP9 EXOC1 EXOC2 | 2.41e-04 | 703 | 205 | 18 | GO:0051640 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | ADAD1 CDK16 CNTLN SIX4 STAT5A STAT5B FANCA FSIP2 PLA2G4A NOS2 NIPBL GOLGA3 ZMYND12 BBOF1 DNHD1 ANGPT2 CASP5 MED1 MEI1 WDR19 GMCL1 AKAP9 CELF1 CCDC42 DDX25 PDE5A | 2.43e-04 | 1235 | 205 | 26 | GO:0003006 |
| GeneOntologyBiologicalProcess | B cell proliferation | 2.44e-04 | 124 | 205 | 7 | GO:0042100 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 2.56e-04 | 125 | 205 | 7 | GO:0046425 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 2.57e-04 | 13 | 205 | 3 | GO:0045136 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 2.79e-04 | 90 | 205 | 6 | GO:0050688 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 2.93e-04 | 3 | 205 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in membrane | 2.93e-04 | 3 | 205 | 2 | GO:0072658 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in plasma membrane | 2.93e-04 | 3 | 205 | 2 | GO:0072660 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | BRIX1 HAUS6 MYH10 MYH11 CENPF SIX4 DOCK5 CEP120 BRCA1 KIF15 TRAF7 HAUS2 SPAG5 KIF4B | 3.01e-04 | 475 | 205 | 14 | GO:0140694 |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | ADAD1 CDK16 CNTLN STAT5A STAT5B FANCA FSIP2 PLA2G4A NOS2 GOLGA3 ZMYND12 BBOF1 DNHD1 ANGPT2 APLP2 MED1 MEI1 ORC4 GMCL1 MLH3 AKAP9 CELF1 CCDC42 DDX25 PDE5A | 3.49e-04 | 1194 | 205 | 25 | GO:0048609 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | SNF8 MYH10 MAP1B CENPF EXOC3 CEP120 KIF5A DCTN2 PCLO MEI1 MADD SPAG5 CEP55 EXOC1 EXOC2 | 3.87e-04 | 546 | 205 | 15 | GO:0051656 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH10 MYH11 MYO1E MYO6 SPTB SPTBN1 PFDN1 SIX4 NF1 FMN1 TLN2 FERMT2 PCLO CASP5 SEMA5A CCDC88A MYH14 SIPA1L1 FGD6 | 4.34e-04 | 803 | 205 | 19 | GO:0030036 |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | 4.34e-04 | 225 | 205 | 9 | GO:0030705 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | HAUS6 MAP1B SPTB SPTBN1 PFDN1 AEBP1 FMN1 FERMT2 CAMSAP2 SEMA5A HAUS2 CCDC88A AKAP9 | 4.62e-04 | 438 | 205 | 13 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 5.78e-04 | 143 | 205 | 7 | GO:1904892 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 5.82e-04 | 4 | 205 | 2 | GO:0071596 | |
| GeneOntologyBiologicalProcess | myotome development | 5.82e-04 | 4 | 205 | 2 | GO:0061055 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization | 6.20e-04 | 69 | 205 | 5 | GO:0031113 | |
| GeneOntologyBiologicalProcess | defense response to virus | LYST TLR8 USP29 IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 EXOC1 | 6.54e-04 | 342 | 205 | 11 | GO:0051607 |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane transport | 6.62e-04 | 70 | 205 | 5 | GO:0006893 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | HAUS6 MAP1B BBS1 CEP120 BRCA1 CAMSAP2 HAUS2 SPAG5 AKAP9 DNAH11 | 7.30e-04 | 293 | 205 | 10 | GO:0032886 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | SNF8 HAUS6 SLK MAP1B SPTB SPTBN1 PYDC2 ATG2A SIX4 CEP120 BRCA1 SACS FMN1 TGFBRAP1 FERMT2 CAMSAP2 LRFN1 GNL3L CASP5 HAUS2 SPAG5 CCDC88A AKAP9 SIPA1L1 | 7.72e-04 | 1189 | 205 | 24 | GO:0044087 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH10 MYH11 MYO1E MYO6 SPTB SPTBN1 PFDN1 SIX4 NF1 FMN1 TLN2 FERMT2 PCLO CASP5 SEMA5A CCDC88A AKAP9 MYH14 SIPA1L1 FGD6 | 7.95e-04 | 912 | 205 | 20 | GO:0030029 |
| GeneOntologyBiologicalProcess | chromosome segregation | HAUS6 CENPF BRCA1 KIF15 NIPBL DCTN2 MEI1 HAUS2 SPAG5 CEP55 MLH3 SMARCC2 KIF4B | 8.05e-04 | 465 | 205 | 13 | GO:0007059 |
| GeneOntologyBiologicalProcess | gamete generation | ADAD1 CDK16 CNTLN FANCA FSIP2 PLA2G4A NOS2 GOLGA3 ZMYND12 BBOF1 DNHD1 ANGPT2 MEI1 ORC4 GMCL1 MLH3 AKAP9 CELF1 CCDC42 DDX25 PDE5A | 8.10e-04 | 982 | 205 | 21 | GO:0007276 |
| GeneOntologyBiologicalProcess | transport along microtubule | 8.16e-04 | 197 | 205 | 8 | GO:0010970 | |
| GeneOntologyBiologicalProcess | presynaptic actin cytoskeleton organization | 9.64e-04 | 5 | 205 | 2 | GO:0099140 | |
| GeneOntologyBiologicalProcess | alkaloid catabolic process | 9.64e-04 | 5 | 205 | 2 | GO:0009822 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 1.00e-03 | 253 | 205 | 9 | GO:0099111 | |
| GeneOntologyBiologicalProcess | protein localization to cilium | 1.02e-03 | 77 | 205 | 5 | GO:0061512 | |
| GeneOntologyCellularComponent | microtubule associated complex | HAUS6 MAP1B KIF15 KIF5A DNHD1 DCTN2 KIF21A KLC2 HAUS2 KIF4B DNAH11 | 4.68e-07 | 161 | 201 | 11 | GO:0005875 |
| GeneOntologyCellularComponent | microtubule organizing center | HAUS6 RAPGEF6 CENPF HIPK1 BBS1 CCDC178 CNTLN BIRC6 CEP120 BRCA1 KIF15 SCLT1 CAMSAP2 BBOF1 CCHCR1 DCTN2 IFT74 RILPL1 CCDC141 HAUS2 SPAG5 CEP55 CCDC88A AKAP9 CCDC42 TXNDC9 | 8.43e-07 | 919 | 201 | 26 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | HAUS6 RAPGEF6 CENPF HIPK1 BBS1 CNTLN BIRC6 CEP120 BRCA1 KIF15 SCLT1 CAMSAP2 DCTN2 IFT74 RILPL1 CCDC141 HAUS2 SPAG5 CEP55 CCDC88A AKAP9 CCDC42 TXNDC9 | 1.54e-06 | 770 | 201 | 23 | GO:0005813 |
| GeneOntologyCellularComponent | cilium | MAP1B CENPF BBS1 CCDC178 PIK3R4 FSIP2 KIF5A SCLT1 CAMSAP2 ZMYND12 BBOF1 DNHD1 IFT74 KLC2 RILPL1 AK8 SPAG5 WDR19 CCDC88A AKAP9 CCDC42 DNAH11 | 5.66e-05 | 898 | 201 | 22 | GO:0005929 |
| GeneOntologyCellularComponent | midbody | MYH10 CENPF EXOC3 BIRC6 SPAG5 CEP55 TXNDC9 KIF4B EXOC1 EXOC2 | 6.03e-05 | 222 | 201 | 10 | GO:0030496 |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 7.05e-05 | 9 | 201 | 3 | GO:0014731 | |
| GeneOntologyCellularComponent | ciliary basal body | 1.17e-04 | 195 | 201 | 9 | GO:0036064 | |
| GeneOntologyCellularComponent | myosin complex | 2.57e-04 | 59 | 201 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin II filament | 2.74e-04 | 3 | 201 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | Flemming body | 3.84e-04 | 36 | 201 | 4 | GO:0090543 | |
| GeneOntologyCellularComponent | ciliary rootlet | 4.47e-04 | 16 | 201 | 3 | GO:0035253 | |
| GeneOntologyCellularComponent | sperm head-tail coupling apparatus | 6.42e-04 | 18 | 201 | 3 | GO:0120212 | |
| GeneOntologyCellularComponent | vesicle tethering complex | 6.49e-04 | 72 | 201 | 5 | GO:0099023 | |
| GeneOntologyCellularComponent | microtubule | HAUS6 MAP1B TCP11L1 KIF15 KIF5A CAMSAP2 DCTN2 KIF21A BAG2 KLC2 HAUS2 SPAG5 KIF4B DNAH11 | 6.77e-04 | 533 | 201 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | motile cilium | BBS1 FSIP2 ZMYND12 BBOF1 DNHD1 IFT74 AK8 WDR19 AKAP9 CCDC42 DNAH11 | 6.77e-04 | 355 | 201 | 11 | GO:0031514 |
| GeneOntologyCellularComponent | cell cortex | MYH10 MYO1E MYO6 SPTB SPTBN1 EXOC3 FERMT2 NOS2 PCLO EXOC1 EXOC2 | 9.70e-04 | 371 | 201 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | supramolecular fiber | HAUS6 MYH10 MYH11 MAP1B MYO6 TCP11L1 SPTBN1 KIF15 FMN1 KIF5A FERMT2 CAMSAP2 ANK3 DCTN2 KIF21A BAG2 KLC2 HAUS2 SPAG5 MYH14 KIF4B TNNI2 DNAH11 | 1.00e-03 | 1179 | 201 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | exocyst | 1.03e-03 | 21 | 201 | 3 | GO:0000145 | |
| GeneOntologyCellularComponent | supramolecular polymer | HAUS6 MYH10 MYH11 MAP1B MYO6 TCP11L1 SPTBN1 KIF15 FMN1 KIF5A FERMT2 CAMSAP2 ANK3 DCTN2 KIF21A BAG2 KLC2 HAUS2 SPAG5 MYH14 KIF4B TNNI2 DNAH11 | 1.10e-03 | 1187 | 201 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | kinesin complex | 1.25e-03 | 49 | 201 | 4 | GO:0005871 | |
| GeneOntologyCellularComponent | centriole | 1.41e-03 | 172 | 201 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH10 MYH11 MYO1E MYO6 SPTB SPTBN1 DOCK5 FMN1 TLN2 FERMT2 DCTN2 MYH14 SIPA1L1 TNNI2 | 1.42e-03 | 576 | 201 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | myosin filament | 1.72e-03 | 25 | 201 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.20e-03 | 238 | 201 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | myosin II complex | 2.40e-03 | 28 | 201 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | axon | MYH10 MAP1B MYO6 SPTBN1 EXOC3 PLXND1 NF1 SACS KIF5A ALK ANK3 DCTN2 KIF21A PCLO BAG2 GRM1 MADD MYH14 | 2.47e-03 | 891 | 201 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | HAUS complex | 2.48e-03 | 8 | 201 | 2 | GO:0070652 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.63e-03 | 360 | 201 | 10 | GO:0099568 | |
| GeneOntologyCellularComponent | clathrin complex | 3.17e-03 | 9 | 201 | 2 | GO:0071439 | |
| GeneOntologyCellularComponent | spectrin | 3.17e-03 | 9 | 201 | 2 | GO:0008091 | |
| Domain | Interferon | 2.58e-10 | 17 | 200 | 7 | PF00143 | |
| Domain | INTERFERON_A_B_D | 2.58e-10 | 17 | 200 | 7 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 2.58e-10 | 17 | 200 | 7 | IPR000471 | |
| Domain | IFabd | 2.58e-10 | 17 | 200 | 7 | SM00076 | |
| Domain | 4_helix_cytokine-like_core | 9.37e-08 | 74 | 200 | 9 | IPR009079 | |
| Domain | - | 9.83e-07 | 50 | 200 | 7 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 1.13e-06 | 51 | 200 | 7 | IPR012351 | |
| Domain | Cyt_P450_E_grp-II | 1.19e-05 | 5 | 200 | 3 | IPR002402 | |
| Domain | ARM-type_fold | PDS5B CLTCL1 TRIP12 LYST PDCD4 PIK3R4 DOCK5 NF1 ARMH3 NIPBL TARBP1 IPO8 MEI1 RANBP17 | 1.82e-05 | 339 | 200 | 14 | IPR016024 |
| Domain | Plexin_repeat | 2.13e-05 | 32 | 200 | 5 | IPR002165 | |
| Domain | PSI | 2.13e-05 | 32 | 200 | 5 | PF01437 | |
| Domain | Cyt_P450_E_CYP3A | 2.36e-05 | 6 | 200 | 3 | IPR008072 | |
| Domain | STAT_TF_DNA-bd_sub | 4.10e-05 | 7 | 200 | 3 | IPR012345 | |
| Domain | STAT | 4.10e-05 | 7 | 200 | 3 | IPR001217 | |
| Domain | Clathrin | 4.10e-05 | 7 | 200 | 3 | PF00637 | |
| Domain | STAT_int | 4.10e-05 | 7 | 200 | 3 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 4.10e-05 | 7 | 200 | 3 | IPR013801 | |
| Domain | STAT_bind | 4.10e-05 | 7 | 200 | 3 | PF02864 | |
| Domain | STAT_int | 4.10e-05 | 7 | 200 | 3 | PF02865 | |
| Domain | - | 4.10e-05 | 7 | 200 | 3 | 1.10.532.10 | |
| Domain | STAT_alpha | 4.10e-05 | 7 | 200 | 3 | PF01017 | |
| Domain | - | 4.10e-05 | 7 | 200 | 3 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 4.10e-05 | 7 | 200 | 3 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 4.10e-05 | 7 | 200 | 3 | IPR015988 | |
| Domain | - | 4.10e-05 | 7 | 200 | 3 | 2.60.40.630 | |
| Domain | Myosin_head_motor_dom | 5.04e-05 | 38 | 200 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.04e-05 | 38 | 200 | 5 | PS51456 | |
| Domain | Myosin_head | 5.04e-05 | 38 | 200 | 5 | PF00063 | |
| Domain | MYSc | 5.04e-05 | 38 | 200 | 5 | SM00242 | |
| Domain | Clathrin_H-chain/VPS_repeat | 6.51e-05 | 8 | 200 | 3 | IPR000547 | |
| Domain | STAT_TF_alpha | 6.51e-05 | 8 | 200 | 3 | IPR013800 | |
| Domain | PSI | 1.04e-04 | 44 | 200 | 5 | IPR016201 | |
| Domain | CCDC74 | 1.14e-04 | 2 | 200 | 2 | IPR033226 | |
| Domain | CCDC74_C | 1.14e-04 | 2 | 200 | 2 | IPR029422 | |
| Domain | CCDC74_C | 1.14e-04 | 2 | 200 | 2 | PF14917 | |
| Domain | PSI | 1.29e-04 | 46 | 200 | 5 | SM00423 | |
| Domain | - | BBS1 PLXND1 BIRC6 LYST PIK3R4 SEMA6D TRAF7 KIF21A COP1 SEMA5A WDR19 SEMA3D | 2.60e-04 | 333 | 200 | 12 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | BBS1 PLXND1 BIRC6 LYST PIK3R4 SEMA6D TRAF7 KIF21A COP1 SEMA5A WDR19 SEMA3D | 2.75e-04 | 335 | 200 | 12 | IPR015943 |
| Domain | P-loop_NTPase | MYH10 MYH11 SAMD9 MYO1E MYO6 ABCA13 IDNK TRANK1 KIF15 KIF5A DNHD1 GNL3L KIF21A DHX57 NLRP2 AK8 ORC4 MYH14 DDX25 KIF4B DNAH11 | 3.13e-04 | 848 | 200 | 21 | IPR027417 |
| Domain | Semap_dom | 3.20e-04 | 31 | 200 | 4 | IPR001627 | |
| Domain | SEMA | 3.20e-04 | 31 | 200 | 4 | PS51004 | |
| Domain | Sema | 3.20e-04 | 31 | 200 | 4 | SM00630 | |
| Domain | Sema | 3.20e-04 | 31 | 200 | 4 | PF01403 | |
| Domain | Myosin_N | 5.01e-04 | 15 | 200 | 3 | PF02736 | |
| Domain | Myosin_N | 5.01e-04 | 15 | 200 | 3 | IPR004009 | |
| Domain | Spectrin_bsu | 6.75e-04 | 4 | 200 | 2 | IPR016343 | |
| Domain | Myosin_tail_1 | 8.77e-04 | 18 | 200 | 3 | PF01576 | |
| Domain | Myosin_tail | 8.77e-04 | 18 | 200 | 3 | IPR002928 | |
| Domain | IQ | 9.84e-04 | 71 | 200 | 5 | PF00612 | |
| Domain | Myosin-like_IQ_dom | 1.03e-03 | 19 | 200 | 3 | IPR027401 | |
| Domain | - | 1.03e-03 | 19 | 200 | 3 | 4.10.270.10 | |
| Domain | Myosin_S1_N | 1.12e-03 | 5 | 200 | 2 | IPR008989 | |
| Domain | Autophagy-rel_C | 1.12e-03 | 5 | 200 | 2 | IPR015412 | |
| Domain | ATG_C | 1.12e-03 | 5 | 200 | 2 | PF09333 | |
| Domain | Kinesin-like_fam | 1.14e-03 | 43 | 200 | 4 | IPR027640 | |
| Domain | Semaphorin | 1.21e-03 | 20 | 200 | 3 | IPR027231 | |
| Domain | - | 1.24e-03 | 44 | 200 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 1.24e-03 | 44 | 200 | 4 | PF00225 | |
| Domain | KISc | 1.24e-03 | 44 | 200 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.24e-03 | 44 | 200 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.24e-03 | 44 | 200 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.24e-03 | 44 | 200 | 4 | PS50067 | |
| Domain | Spectrin | 1.83e-03 | 23 | 200 | 3 | PF00435 | |
| Domain | ZnF_UBR1 | 2.31e-03 | 7 | 200 | 2 | SM00396 | |
| Domain | ZF_UBR | 2.31e-03 | 7 | 200 | 2 | PS51157 | |
| Domain | zf-UBR | 2.31e-03 | 7 | 200 | 2 | PF02207 | |
| Domain | CHCR | 2.31e-03 | 7 | 200 | 2 | PS50236 | |
| Domain | Znf_UBR | 2.31e-03 | 7 | 200 | 2 | IPR003126 | |
| Domain | Cyt_P450_CS | 2.48e-03 | 53 | 200 | 4 | IPR017972 | |
| Domain | ARM-like | 2.59e-03 | 270 | 200 | 9 | IPR011989 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 2.56e-11 | 31 | 152 | 9 | M47964 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 4.27e-11 | 22 | 152 | 8 | M47897 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 2.62e-10 | 17 | 152 | 7 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 4.25e-10 | 18 | 152 | 7 | M47539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 6.67e-10 | 19 | 152 | 7 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 1.02e-09 | 20 | 152 | 7 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.51e-09 | 21 | 152 | 7 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 2.20e-09 | 22 | 152 | 7 | M47616 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 2.79e-09 | 35 | 152 | 8 | M6382 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 3.13e-09 | 23 | 152 | 7 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 3.13e-09 | 23 | 152 | 7 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 4.38e-09 | 24 | 152 | 7 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 4.38e-09 | 24 | 152 | 7 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 4.38e-09 | 24 | 152 | 7 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 8.17e-09 | 26 | 152 | 7 | M982 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 2.44e-08 | 30 | 152 | 7 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 3.12e-08 | 31 | 152 | 7 | M39897 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 3.44e-08 | 19 | 152 | 6 | MM1571 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | DOCK5 KIF15 KIF5A KIF21A KLC2 IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 KIF4B | 3.69e-08 | 170 | 152 | 13 | M941 |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 6.22e-08 | 34 | 152 | 7 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 7.70e-08 | 35 | 152 | 7 | M48246 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 1.16e-07 | 37 | 152 | 7 | M39785 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 4.41e-07 | 28 | 152 | 6 | MM1378 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 4.56e-07 | 65 | 152 | 8 | M272 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 1.08e-06 | 98 | 152 | 9 | M48247 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 1.24e-06 | 33 | 152 | 6 | MM1379 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 1.31e-06 | 52 | 152 | 7 | M13103 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 1.94e-06 | 55 | 152 | 7 | M11844 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 3.46e-06 | 39 | 152 | 6 | MM15914 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 4.32e-06 | 87 | 152 | 8 | MM15915 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 4.69e-06 | 41 | 152 | 6 | MM1493 | |
| Pathway | WP_HEPATITIS_B_INFECTION | STAT4 STAT5A STAT5B IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 | 5.39e-06 | 151 | 152 | 10 | M39801 |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 5.87e-06 | 120 | 152 | 9 | M48233 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | STAT4 STAT5A STAT5B IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 | 6.81e-06 | 155 | 152 | 10 | M17411 |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 8.75e-06 | 126 | 152 | 9 | M45009 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.10e-05 | 71 | 152 | 7 | M15913 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | HAUS6 BBS1 EXOC3 SCLT1 DCTN2 IFT74 HAUS2 WDR19 AKAP9 EXOC1 EXOC2 | 1.13e-05 | 201 | 152 | 11 | M27472 |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.21e-05 | 5 | 152 | 3 | M48987 | |
| Pathway | REACTOME_HEMOSTASIS | ITIH4 ITPR3 DOCK5 KIF15 PLA2G4A KIF5A NOS2 ANGPT2 KIF21A KLC2 APLP2 IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 MMRN1 PDE5A KIF4B | 1.26e-05 | 679 | 152 | 21 | M8395 |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 1.31e-05 | 29 | 152 | 5 | M2920 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 1.33e-05 | 73 | 152 | 7 | M39837 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.41e-05 | 102 | 152 | 8 | M3261 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | SNF8 CLTCL1 MYO6 SPTB SPTBN1 EXOC3 STX5 KIF15 PLA2G4A KIF5A GOLGB1 ANK3 DCTN2 COG7 KIF21A KLC2 MADD KIF4B EXOC1 EXOC2 | 1.42e-05 | 630 | 152 | 20 | M11480 |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 1.52e-05 | 103 | 152 | 8 | M39434 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 1.62e-05 | 136 | 152 | 9 | M42547 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.05e-05 | 78 | 152 | 7 | M973 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | SLK MYH10 MYH11 MYO6 CENPF SPTBN1 MTMR1 PLXND1 SOWAHC PIK3R4 DOCK5 STX5 SRGAP1 KIF5A FERMT2 GOLGA3 KLC2 CCDC88A MYH14 PDE5A | 2.18e-05 | 649 | 152 | 20 | MM15690 |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | HAUS6 BBS1 EXOC3 SCLT1 DCTN2 IFT74 HAUS2 WDR19 AKAP9 EXOC1 EXOC2 | 2.31e-05 | 217 | 152 | 11 | MM14708 |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 2.85e-05 | 82 | 152 | 7 | M1002 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | SLK MYH10 MYH11 MYO6 CENPF KDM4C SPTBN1 MTMR1 PLXND1 SOWAHC PIK3R4 DOCK5 STX5 SRGAP1 KIF5A FERMT2 GOLGA3 KLC2 CCDC88A MYH14 PDE5A | 3.02e-05 | 720 | 152 | 21 | M41838 |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 4.44e-05 | 19 | 152 | 4 | M41732 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 4.51e-05 | 88 | 152 | 7 | M16004 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 6.37e-05 | 64 | 152 | 6 | M7923 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | HAUS6 BBS1 EXOC3 SCLT1 DCTN2 IFT74 MED1 HAUS2 WDR19 AKAP9 EXOC1 EXOC2 | 9.01e-05 | 297 | 152 | 12 | M27050 |
| Pathway | REACTOME_XENOBIOTICS | 9.81e-05 | 23 | 152 | 4 | M5372 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | SNF8 CLTCL1 MYO6 SPTB SPTBN1 EXOC3 STX5 KIF15 PLA2G4A KIF5A GOLGB1 ANK3 DCTN2 COG7 KIF21A KLC2 MADD KIF4B EXOC1 EXOC2 | 1.02e-04 | 725 | 152 | 20 | M27507 |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.16e-04 | 102 | 152 | 7 | M27648 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.24e-04 | 138 | 152 | 8 | MM15635 | |
| Pathway | REACTOME_INSULIN_PROCESSING | 1.38e-04 | 25 | 152 | 4 | M27198 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.40e-04 | 10 | 152 | 3 | M27898 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 2.09e-04 | 189 | 152 | 9 | MM15356 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 2.17e-04 | 28 | 152 | 4 | M41724 | |
| Pathway | REACTOME_INSULIN_PROCESSING | 3.25e-04 | 13 | 152 | 3 | MM14909 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 3.55e-04 | 203 | 152 | 9 | M27654 | |
| Pathway | REACTOME_KINESINS | 3.64e-04 | 57 | 152 | 5 | MM15714 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 3.68e-04 | 204 | 152 | 9 | M45011 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 4.10e-04 | 14 | 152 | 3 | MM15047 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 4.48e-04 | 127 | 152 | 7 | M42533 | |
| Pathway | REACTOME_KINESINS | 4.99e-04 | 61 | 152 | 5 | M977 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 5.40e-04 | 131 | 152 | 7 | MM15497 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 6.18e-04 | 134 | 152 | 7 | M27751 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 7.05e-04 | 137 | 152 | 7 | M5669 | |
| Pathway | REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE | 7.97e-04 | 39 | 152 | 4 | MM15209 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | SLK MYO6 SPTBN1 MTMR1 PLXND1 SOWAHC DOCK5 STX5 SRGAP1 FERMT2 GOLGA3 CCDC88A PDE5A | 9.37e-04 | 439 | 152 | 13 | MM15595 |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 1.05e-03 | 19 | 152 | 3 | M10959 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.05e-03 | 19 | 152 | 3 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 1.05e-03 | 19 | 152 | 3 | M27489 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 1.13e-03 | 5 | 152 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 1.13e-03 | 5 | 152 | 2 | M49006 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | SLK MYO6 SPTBN1 MTMR1 PLXND1 SOWAHC DOCK5 STX5 SRGAP1 FERMT2 GOLGA3 CCDC88A PDE5A | 1.17e-03 | 450 | 152 | 13 | M27078 |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.21e-03 | 110 | 152 | 6 | MM15350 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.22e-03 | 20 | 152 | 3 | M18415 | |
| Pathway | REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM | 1.22e-03 | 20 | 152 | 3 | MM15208 | |
| Pathway | REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM | 1.42e-03 | 21 | 152 | 3 | M27479 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.42e-03 | 21 | 152 | 3 | M27494 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.51e-03 | 156 | 152 | 7 | M27097 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.60e-03 | 116 | 152 | 6 | MM15715 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.68e-03 | 6 | 152 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.68e-03 | 6 | 152 | 2 | MM15621 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.86e-03 | 23 | 152 | 3 | MM15222 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 2.11e-03 | 24 | 152 | 3 | M2243 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.11e-03 | 24 | 152 | 3 | M13404 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 2.11e-03 | 24 | 152 | 3 | M46445 | |
| Pathway | REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE | 2.19e-03 | 51 | 152 | 4 | M27480 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 2.34e-03 | 7 | 152 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 2.34e-03 | 7 | 152 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 2.34e-03 | 7 | 152 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 2.34e-03 | 7 | 152 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 2.34e-03 | 7 | 152 | 2 | M27907 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 2.35e-03 | 52 | 152 | 4 | M2404 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 1.98e-13 | 12 | 209 | 7 | 16611902 | |
| Pubmed | 1.98e-13 | 12 | 209 | 7 | 8245849 | ||
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 1.98e-13 | 12 | 209 | 7 | 7530016 | |
| Pubmed | 1.98e-13 | 12 | 209 | 7 | 9794206 | ||
| Pubmed | 1.98e-13 | 12 | 209 | 7 | 16565497 | ||
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 1.98e-13 | 12 | 209 | 7 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 1.98e-13 | 12 | 209 | 7 | 1886773 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 1.98e-13 | 12 | 209 | 7 | 7684767 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 1.98e-13 | 12 | 209 | 7 | 22912583 | |
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 1.98e-13 | 12 | 209 | 7 | 3758677 | |
| Pubmed | 1.98e-13 | 12 | 209 | 7 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 1.98e-13 | 12 | 209 | 7 | 8760352 | |
| Pubmed | 1.98e-13 | 12 | 209 | 7 | 17451966 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 4.26e-13 | 13 | 209 | 7 | 12930842 | |
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 2471809 | ||
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 8438572 | ||
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 9343822 | ||
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 19706714 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 4.26e-13 | 13 | 209 | 7 | 2987810 | |
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 19130550 | ||
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 4.26e-13 | 13 | 209 | 7 | 2014240 | |
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 18005734 | ||
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 4.26e-13 | 13 | 209 | 7 | 6094686 | |
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 1655578 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 4.26e-13 | 13 | 209 | 7 | 23255800 | |
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 7523540 | ||
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 22739040 | ||
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 9181467 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 4.26e-13 | 13 | 209 | 7 | 18726328 | |
| Pubmed | 4.26e-13 | 13 | 209 | 7 | 18572754 | ||
| Pubmed | Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. | 8.47e-13 | 14 | 209 | 7 | 8668211 | |
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 8.47e-13 | 14 | 209 | 7 | 7526537 | |
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 19559726 | ||
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 8.47e-13 | 14 | 209 | 7 | 7532202 | |
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 8.47e-13 | 14 | 209 | 7 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 8.47e-13 | 14 | 209 | 7 | 17517919 | |
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 25972534 | ||
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 7583919 | ||
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 2987811 | ||
| Pubmed | Characterization of the murine alpha interferon gene family. | 8.47e-13 | 14 | 209 | 7 | 15254193 | |
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 8345204 | ||
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 15240719 | ||
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 16418394 | ||
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 18272764 | ||
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 11884139 | ||
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 19004943 | ||
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 14983024 | ||
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 21172865 | ||
| Pubmed | 8.47e-13 | 14 | 209 | 7 | 16278001 | ||
| Pubmed | Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. | 8.47e-13 | 14 | 209 | 7 | 1381203 | |
| Pubmed | 1.58e-12 | 15 | 209 | 7 | 8786318 | ||
| Pubmed | 1.58e-12 | 15 | 209 | 7 | 15684736 | ||
| Pubmed | 1.58e-12 | 15 | 209 | 7 | 9520456 | ||
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 1.58e-12 | 15 | 209 | 7 | 8661419 | |
| Pubmed | Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | 1.58e-12 | 15 | 209 | 7 | 17180012 | |
| Pubmed | Role of the Akt pathway in mRNA translation of interferon-stimulated genes. | 1.58e-12 | 15 | 209 | 7 | 18339807 | |
| Pubmed | Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. | 2.80e-12 | 16 | 209 | 7 | 22315404 | |
| Pubmed | Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. | 2.80e-12 | 16 | 209 | 7 | 7904170 | |
| Pubmed | Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. | 2.80e-12 | 16 | 209 | 7 | 18414664 | |
| Pubmed | 4.73e-12 | 17 | 209 | 7 | 22814248 | ||
| Pubmed | Characterization of the type I interferon locus and identification of novel genes. | 4.73e-12 | 17 | 209 | 7 | 15233997 | |
| Pubmed | 7.70e-12 | 18 | 209 | 7 | 1905933 | ||
| Pubmed | 1.21e-11 | 19 | 209 | 7 | 7815507 | ||
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 1.21e-11 | 19 | 209 | 7 | 1708818 | |
| Pubmed | 1.21e-11 | 19 | 209 | 7 | 7511078 | ||
| Pubmed | 1.21e-11 | 19 | 209 | 7 | 17360657 | ||
| Pubmed | 1.21e-11 | 19 | 209 | 7 | 1385305 | ||
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 1.86e-11 | 20 | 209 | 7 | 11694501 | |
| Pubmed | 1.86e-11 | 20 | 209 | 7 | 8764000 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 1.97e-11 | 11 | 209 | 6 | 6444699 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 1.97e-11 | 11 | 209 | 6 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 1.97e-11 | 11 | 209 | 6 | 15795237 | |
| Pubmed | 1.97e-11 | 11 | 209 | 6 | 9794439 | ||
| Pubmed | 1.97e-11 | 11 | 209 | 6 | 18835032 | ||
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 1.97e-11 | 11 | 209 | 6 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 1.97e-11 | 11 | 209 | 6 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 1.97e-11 | 11 | 209 | 6 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 1.97e-11 | 11 | 209 | 6 | 3456887 | |
| Pubmed | 1.97e-11 | 11 | 209 | 6 | 25310498 | ||
| Pubmed | 2.77e-11 | 21 | 209 | 7 | 9108403 | ||
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 3.93e-11 | 12 | 209 | 6 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 3.93e-11 | 12 | 209 | 6 | 27988795 | |
| Pubmed | 3.93e-11 | 12 | 209 | 6 | 8656058 | ||
| Pubmed | 3.93e-11 | 12 | 209 | 6 | 6188104 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 3.93e-11 | 12 | 209 | 6 | 18716002 | |
| Pubmed | 3.93e-11 | 12 | 209 | 6 | 30967261 | ||
| Pubmed | 3.93e-11 | 12 | 209 | 6 | 17434974 | ||
| Pubmed | 3.93e-11 | 12 | 209 | 6 | 3017340 | ||
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 3.93e-11 | 12 | 209 | 6 | 1360280 | |
| Pubmed | 3.93e-11 | 12 | 209 | 6 | 7601556 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 3.93e-11 | 12 | 209 | 6 | 21320124 | |
| Pubmed | 3.93e-11 | 12 | 209 | 6 | 9425112 | ||
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 3.93e-11 | 12 | 209 | 6 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 3.93e-11 | 12 | 209 | 6 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 3.93e-11 | 12 | 209 | 6 | 32016282 | |
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 3.93e-11 | 12 | 209 | 6 | 26277892 | |
| Pubmed | 3.93e-11 | 12 | 209 | 6 | 6689487 | ||
| Interaction | NDC80 interactions | HAUS6 PFDN1 CNTLN BIRC6 KIF15 CCDC138 SCLT1 CAMSAP2 GOLGA3 CCHCR1 IFT74 COP1 HAUS2 SPAG5 CEP55 TRIM67 AKAP9 EXOC1 | 3.49e-09 | 312 | 205 | 18 | int:NDC80 |
| Interaction | SEPTIN10 interactions | CENPF BRCA1 KIF15 CCDC138 GOLGB1 IFT74 SPAG5 CEP55 CCDC88A TRIM67 AKAP9 SIPA1L1 | 2.85e-08 | 144 | 205 | 12 | int:SEPTIN10 |
| Interaction | MED4 interactions | BRIX1 HAUS6 SLK MYH11 MAP1B CEP120 CCDC138 KIF5A CCHCR1 DCTN2 IFT74 POLR2A MED1 HAUS2 SPAG5 CEP55 TRIM67 SUPT16H TXNDC9 EXOC1 | 3.79e-08 | 450 | 205 | 20 | int:MED4 |
| Interaction | KXD1 interactions | CENPF EXOC3 STX5 KIF15 KIF5A GOLGA3 TRAF7 CCHCR1 IFT74 SPAG5 CEP55 EXOC1 | 1.78e-07 | 170 | 205 | 12 | int:KXD1 |
| Interaction | FBXO22 interactions | PDS5B MYO6 CENPF KDM4C SPTBN1 EXOC3 TRIP12 STAT5A PIK3R4 TRANK1 KIF15 ARMH3 GNL3L ANK3 POLR2A BAG2 KLC2 DHX57 MEI1 TRIM67 | 7.02e-07 | 540 | 205 | 20 | int:FBXO22 |
| Interaction | H2BC9 interactions | PDS5B MYH10 MAP1B MYO6 ABCA13 HPSE2 ATG2A PDCD4 FSIP2 KIF5A PCLO POLR2A TRIM67 SUPT16H SMARCC2 PDE5A KIF4B FGD6 | 7.66e-07 | 446 | 205 | 18 | int:H2BC9 |
| Interaction | IFNA13 interactions | 3.24e-06 | 11 | 205 | 4 | int:IFNA13 | |
| Interaction | DCTN1 interactions | HAUS6 MYO6 SPTBN1 BBS1 PFDN1 NF1 BRCA1 CCDC138 CAMSAP2 IPO8 DCTN2 IFT74 DHX57 SPAG5 CEP55 CCDC88A TRIM67 SUPT16H | 3.54e-06 | 497 | 205 | 18 | int:DCTN1 |
| Interaction | WHAMMP3 interactions | 3.60e-06 | 119 | 205 | 9 | int:WHAMMP3 | |
| Interaction | CIT interactions | BRIX1 PDS5B HAUS6 MYH10 MYH11 CLTCL1 MYO1E MYO6 CENPF HIPK1 SPTB SPTBN1 PLXND1 TRIP12 BIRC6 ITIH4 ITPR3 BRCA1 FERMT2 NIPBL TARBP1 CHERP RBM4B PCLO POLR2A BAG2 DHX57 MED1 TRIM67 AKAP9 CCDC42 MYH14 SUPT16H SMARCC2 | 4.04e-06 | 1450 | 205 | 34 | int:CIT |
| Interaction | MAPRE3 interactions | CENPF PIK3R4 KIF15 CAMSAP2 DCTN2 IFT74 KIF21A SPAG5 CEP55 CCDC88A TRIM67 AKAP9 | 4.38e-06 | 230 | 205 | 12 | int:MAPRE3 |
| Interaction | CEP135 interactions | HAUS6 CNTLN CEP120 CCDC138 GOLGB1 CCHCR1 IFT74 ISOC1 HAUS2 CEP55 CCDC88A AKAP9 SIPA1L1 | 4.55e-06 | 272 | 205 | 13 | int:CEP135 |
| Interaction | KIAA0753 interactions | HAUS6 MYO6 CEP120 CCDC138 CAMSAP2 CCHCR1 BAG2 HAUS2 SPAG5 CEP55 | 4.87e-06 | 157 | 205 | 10 | int:KIAA0753 |
| Interaction | PFN1 interactions | RAPGEF6 VPS13C SPTBN1 SOWAHC BIRC6 STX5 NF1 BRCA1 KIF15 GOLGA3 GOLGB1 DOP1B IFT74 PCLO ELP1 SPAG5 TRIM67 AKAP9 | 4.93e-06 | 509 | 205 | 18 | int:PFN1 |
| Interaction | KRT18 interactions | MAP1B BBS1 BIRC6 ITPR3 BRCA1 KIF15 CCDC138 NOS2 ALK CCHCR1 IFT74 HAUS2 SPAG5 CEP55 TRIM67 CCDC42 | 6.50e-06 | 419 | 205 | 16 | int:KRT18 |
| Interaction | COG6 interactions | SYCP2L CENPF KIF5A ARMH3 CCHCR1 COG7 KLC2 SPAG5 TRIM67 EXOC1 | 7.17e-06 | 164 | 205 | 10 | int:COG6 |
| Interaction | LRRC31 interactions | MYH10 MYH11 MYO6 TRIP12 ITPR3 DOCK5 TMTC3 DHX57 MED1 MYH14 SUPT16H | 8.48e-06 | 205 | 205 | 11 | int:LRRC31 |
| Interaction | BORCS6 interactions | PLA2G4A SCLT1 CAMSAP2 GOLGB1 CCHCR1 DCTN2 IFT74 BAG2 SPAG5 CEP55 | 9.85e-06 | 170 | 205 | 10 | int:BORCS6 |
| Interaction | PCM1 interactions | HAUS6 MYO6 CNTLN CEP120 KIF15 SRGAP1 CCDC138 SCLT1 CAMSAP2 CCHCR1 IFT74 HAUS2 SPAG5 CEP55 TRIM67 AKAP9 | 1.01e-05 | 434 | 205 | 16 | int:PCM1 |
| Interaction | YWHAZ interactions | CDK16 SLK MYH10 MYH11 RAPGEF6 SPTBN1 MTMR1 TRIP12 LYST IVD FSIP2 NF1 BRCA1 KIF15 SRGAP1 KIF5A FERMT2 CAMSAP2 NOS2 GOLGA3 KLC2 COP1 ISOC1 MADD SPAG5 CCDC88A TRIM67 AKAP9 SIPA1L1 EXOC2 FGD6 | 1.09e-05 | 1319 | 205 | 31 | int:YWHAZ |
| Interaction | KRT8 interactions | RAPGEF6 BIRC6 ITPR3 KIF15 CCDC138 CAMSAP2 NOS2 GOLGA3 RMND5A IPO8 IFT74 ELP1 SPAG5 CEP55 AKAP9 SIPA1L1 | 1.23e-05 | 441 | 205 | 16 | int:KRT8 |
| Interaction | KCTD13 interactions | SLK MYH10 MYH11 MYO1E MAP1B MYO6 SPTB SPTBN1 MTMR1 PIK3R4 NF1 SACS TLN2 FERMT2 CAMSAP2 GOLGA3 ANK3 DCTN2 PCLO TOM1 BAG2 KLC2 ELP1 DHX57 GRM1 MADD SACM1L MYH14 SIPA1L1 SMARCC2 EXOC1 DNAH11 | 1.24e-05 | 1394 | 205 | 32 | int:KCTD13 |
| Interaction | BFSP1 interactions | 1.42e-05 | 52 | 205 | 6 | int:BFSP1 | |
| Interaction | RHOB interactions | PDS5B CDK16 SLK RAPGEF6 MYO1E MYO6 SPTBN1 MTMR1 EXOC3 SOWAHC PRKD3 NF1 SEMA6D TMTC3 FERMT2 GNL3L ANK3 MPZL1 CEP55 CCDC88A SIPA1L1 SUPT16H EXOC2 | 1.62e-05 | 840 | 205 | 23 | int:RHOB |
| Interaction | SYDE1 interactions | 1.69e-05 | 110 | 205 | 8 | int:SYDE1 | |
| Interaction | CPAP interactions | HAUS6 LYST STAT5A STAT5B CEP120 CCDC138 FERMT2 CAMSAP2 KLC2 CEP55 | 1.78e-05 | 182 | 205 | 10 | int:CPAP |
| Interaction | YWHAH interactions | CDK16 MYH11 RAPGEF6 MYO1E SPTBN1 TRIP12 LYST PDCD4 PIK3R4 STX5 NF1 SRGAP1 CCDC138 KIF5A FERMT2 CAMSAP2 DOP1B IFT74 KLC2 ISOC1 MED1 MADD CCDC88A TRIM67 AKAP9 SIPA1L1 FGD6 | 2.09e-05 | 1102 | 205 | 27 | int:YWHAH |
| Interaction | CEP170 interactions | HAUS6 CEP120 BRCA1 CCDC138 SCLT1 IFT74 BAG2 HAUS2 SPAG5 MTAP TRIM67 AKAP9 TXNDC9 | 2.41e-05 | 318 | 205 | 13 | int:CEP170 |
| Interaction | SPICE1 interactions | HAUS6 STAT5A CEP120 CCDC138 CAMSAP2 IPO8 HAUS2 SPAG5 CEP55 SUPT16H | 2.70e-05 | 191 | 205 | 10 | int:SPICE1 |
| Interaction | YWHAE interactions | SNF8 CDK16 MYH10 MYH11 RAPGEF6 MAP1B CNTLN TRIP12 LYST PDCD4 PIK3R4 NF1 BRCA1 SRGAP1 KIF5A FERMT2 CAMSAP2 NOS2 GOLGA3 IPO8 KLC2 ISOC1 CEP55 CCDC88A TRIM67 AKAP9 SIPA1L1 SMARCC2 FGD6 | 3.01e-05 | 1256 | 205 | 29 | int:YWHAE |
| Interaction | KDM1A interactions | ZNF280A SNF8 HAUS6 RAPGEF6 CENPF KDM4C BIRC6 BRCA1 KIF15 SCLT1 GOLGA3 GOLGB1 CCDC74B RMND5A IFT74 POLR2A SPAG5 CCDC88A TRIM67 AKAP9 CCDC74A SUPT16H SMARCC2 EXOC1 | 3.31e-05 | 941 | 205 | 24 | int:KDM1A |
| Interaction | ENO1 interactions | MYH10 MYH11 RAPGEF6 SAMD9 CLTCL1 MYO1E MAP1B MYO6 CENPF C3orf20 ANKRD18B FANCA BRCA1 NOS2 RMND5A ANK3 TOM1 BAG2 TRIM67 MYH14 | 3.36e-05 | 701 | 205 | 20 | int:ENO1 |
| Interaction | KRT19 interactions | HAUS6 BIRC6 KIF15 CCDC138 CCHCR1 DCTN2 IFT74 HAUS2 SPAG5 CEP55 TRIM67 AKAP9 | 3.37e-05 | 282 | 205 | 12 | int:KRT19 |
| Interaction | IFNA16 interactions | 3.52e-05 | 7 | 205 | 3 | int:IFNA16 | |
| Interaction | PSMC5 interactions | SLK MYH10 MAP1B BIRC6 PDCD4 BRCA1 NOS2 CCDC74B RMND5A DCTN2 ELP1 GRM1 TRIM67 CCDC74A SMARCC2 TNNI2 | 3.81e-05 | 484 | 205 | 16 | int:PSMC5 |
| Interaction | PHLPP1 interactions | HAUS6 SLK RAPGEF6 CENPF KIF15 PLA2G4A FERMT2 GOLGB1 POLR2A BAG2 SPAG5 CCDC88A TRIM67 | 3.88e-05 | 333 | 205 | 13 | int:PHLPP1 |
| Interaction | SPSB4 interactions | 4.01e-05 | 124 | 205 | 8 | int:SPSB4 | |
| Interaction | PTPN23 interactions | 4.32e-05 | 162 | 205 | 9 | int:PTPN23 | |
| Interaction | DTNBP1 interactions | 4.32e-05 | 162 | 205 | 9 | int:DTNBP1 | |
| Interaction | RABEP2 interactions | 4.60e-05 | 93 | 205 | 7 | int:RABEP2 | |
| Interaction | IFIT1 interactions | 4.72e-05 | 64 | 205 | 6 | int:IFIT1 | |
| Interaction | SYCE1 interactions | 4.76e-05 | 127 | 205 | 8 | int:SYCE1 | |
| Interaction | PHF21A interactions | HAUS6 RAPGEF6 CENPF BIRC6 KIF15 SCLT1 GOLGA3 GOLGB1 CCHCR1 IFT74 SPAG5 CCDC88A EXOC1 | 5.26e-05 | 343 | 205 | 13 | int:PHF21A |
| Interaction | DYRK1A interactions | MYH11 MYO1E MAP1B CENPF SPTBN1 TRIP12 NF1 BRCA1 FERMT2 CAMSAP2 GOLGB1 DCTN2 HAUS2 CEP55 TRIM67 ATRNL1 SIPA1L1 | 5.26e-05 | 552 | 205 | 17 | int:DYRK1A |
| Interaction | CEP128 interactions | HAUS6 CEP120 CCDC138 SCLT1 FERMT2 CAMSAP2 IPO8 IFT74 POLR2A HAUS2 CEP55 SIPA1L1 | 5.56e-05 | 297 | 205 | 12 | int:CEP128 |
| Interaction | MAGEA9 interactions | HAUS6 RAPGEF6 SAMD9 EXOC3 ITPR3 GNL3L TRIM67 UBR3 TXNDC9 TYW1 | 5.58e-05 | 208 | 205 | 10 | int:MAGEA9 |
| Interaction | IFNA4 interactions | 5.77e-05 | 41 | 205 | 5 | int:IFNA4 | |
| Interaction | CDC5L interactions | SLK SPTBN1 DOCK5 NF1 BRCA1 TLN2 NIPBL GOLGB1 CHERP DCTN2 RBM4B RBM4 KIF21A POLR2A BAG2 ELP1 ORC4 TRIM67 AKAP9 SMARCC2 EXOC1 EXOC2 | 6.31e-05 | 855 | 205 | 22 | int:CDC5L |
| Interaction | PARP4 interactions | 6.50e-05 | 42 | 205 | 5 | int:PARP4 | |
| Interaction | IFNA5 interactions | 6.59e-05 | 22 | 205 | 4 | int:IFNA5 | |
| Interaction | UBR3 interactions | 6.87e-05 | 99 | 205 | 7 | int:UBR3 | |
| Interaction | GYPA interactions | 7.52e-05 | 174 | 205 | 9 | int:GYPA | |
| Interaction | DCTN2 interactions | MYH10 MYO6 KIF15 CCDC138 SCLT1 DCTN2 IFT74 POLR2A SPAG5 CEP55 TRIM67 AKAP9 SMARCC2 | 7.67e-05 | 356 | 205 | 13 | int:DCTN2 |
| Interaction | IFNA7 interactions | 8.33e-05 | 9 | 205 | 3 | int:IFNA7 | |
| Interaction | AMOT interactions | BIRC6 KIF15 CCDC138 SCLT1 CAMSAP2 IFT74 BAG2 HAUS2 SPAG5 CEP55 TRIM67 SIPA1L1 | 8.90e-05 | 312 | 205 | 12 | int:AMOT |
| Interaction | BIRC6 interactions | MYH10 DIPK1A BIRC6 C3orf20 NF1 FERMT2 GOLGB1 RMND5A ISOC1 TRIM67 AKAP9 | 8.96e-05 | 265 | 205 | 11 | int:BIRC6 |
| Interaction | CDK8 interactions | CDK16 BRCA1 SRGAP1 NIPBL RBM4 POLR2A MED1 MLH3 CELF1 SMARCC2 | 9.59e-05 | 222 | 205 | 10 | int:CDK8 |
| Interaction | LPIN3 interactions | 9.94e-05 | 73 | 205 | 6 | int:LPIN3 | |
| Interaction | KIF13B interactions | 1.05e-04 | 142 | 205 | 8 | int:KIF13B | |
| Interaction | EXOC1 interactions | 1.10e-04 | 143 | 205 | 8 | int:EXOC1 | |
| Interaction | PHLDB2 interactions | 1.10e-04 | 143 | 205 | 8 | int:PHLDB2 | |
| Interaction | CLIP1 interactions | 1.11e-04 | 183 | 205 | 9 | int:CLIP1 | |
| Interaction | HAUS1 interactions | 1.11e-04 | 183 | 205 | 9 | int:HAUS1 | |
| Interaction | H2BC11 interactions | 1.25e-04 | 186 | 205 | 9 | int:H2BC11 | |
| Interaction | NANOG interactions | MYO1E CENPF TRIP12 ITPR3 CDAN1 BRCA1 GNL3L CHERP IPO8 RBM4 POLR2A BAG2 MUC16 AKAP9 SUPT16H | 1.27e-04 | 481 | 205 | 15 | int:NANOG |
| Interaction | NPTN interactions | PDS5B CLTCL1 FANCA TARBP1 DOP1B IPO8 COG7 RANBP17 ORC4 TRIM67 EXOC2 | 1.37e-04 | 278 | 205 | 11 | int:NPTN |
| Interaction | CEP43 interactions | 1.47e-04 | 190 | 205 | 9 | int:CEP43 | |
| Interaction | LAMTOR1 interactions | BRIX1 CDK16 MYO6 VPS13C SPTBN1 EXOC3 PIK3R4 PRKD3 STX5 FERMT2 GOLGA3 GOLGB1 RMND5A MPZL1 KLC2 CEP55 CCDC88A TRIM67 FGD6 | 1.53e-04 | 722 | 205 | 19 | int:LAMTOR1 |
| Interaction | CAV1 interactions | RAPGEF6 MYO6 SPTBN1 MTMR1 EXOC3 ITPR3 STX5 NF1 FERMT2 NOS2 GOLGA3 GOLGB1 ANK3 MPZL1 BAG2 CEP55 CCDC88A MTAP TRIM67 | 1.58e-04 | 724 | 205 | 19 | int:CAV1 |
| Interaction | GPR17 interactions | PDS5B EXOC3 FANCA PIK3R4 SACS TARBP1 IPO8 COG7 UBR3 EXOC1 EXOC2 | 1.60e-04 | 283 | 205 | 11 | int:GPR17 |
| Interaction | DUSP16 interactions | HAUS6 RAPGEF6 MAP1B VPS13C MTMR1 CCDC138 COG7 HAUS2 SPAG5 CCDC88A | 1.64e-04 | 237 | 205 | 10 | int:DUSP16 |
| Interaction | IFIT3 interactions | 1.65e-04 | 80 | 205 | 6 | int:IFIT3 | |
| Interaction | NADK interactions | 1.65e-04 | 80 | 205 | 6 | int:NADK | |
| Interaction | CGN interactions | 1.68e-04 | 152 | 205 | 8 | int:CGN | |
| Interaction | ABI2 interactions | ZMYND12 CCHCR1 CCDC74B ANK3 DCTN2 KLC2 PTPRU SPAG5 TRIM67 AKAP9 UBR3 | 1.75e-04 | 286 | 205 | 11 | int:ABI2 |
| Interaction | C3orf18 interactions | 1.76e-04 | 115 | 205 | 7 | int:C3orf18 | |
| Interaction | GRIN1 interactions | 1.83e-04 | 154 | 205 | 8 | int:GRIN1 | |
| Interaction | NMI interactions | 2.07e-04 | 118 | 205 | 7 | int:NMI | |
| Interaction | CYP3A5 interactions | 2.13e-04 | 12 | 205 | 3 | int:CYP3A5 | |
| Interaction | IFNA2 interactions | 2.13e-04 | 12 | 205 | 3 | int:IFNA2 | |
| Interaction | ODF2 interactions | 2.19e-04 | 158 | 205 | 8 | int:ODF2 | |
| Interaction | RHOA interactions | BRIX1 SLK MYO1E MYO6 VPS13C SPTBN1 MTMR1 SOWAHC ITPR3 STX5 NF1 SEMA6D TMTC3 SRGAP1 FERMT2 GOLGA3 GOLGB1 TRAF7 ANK3 MPZL1 APLP2 CEP55 CCDC88A TRIM67 SUPT16H TYW1 | 2.19e-04 | 1199 | 205 | 26 | int:RHOA |
| Interaction | GPR182 interactions | PDS5B EXOC3 FANCA PIK3R4 DOCK5 CCDC138 TARBP1 DOP1B GNL3L IPO8 SACM1L EXOC1 TYW1 EXOC2 | 2.46e-04 | 455 | 205 | 14 | int:GPR182 |
| Interaction | ANK1 interactions | 2.60e-04 | 56 | 205 | 5 | int:ANK1 | |
| Interaction | BSG interactions | PDS5B MAP1B SPTB EXOC3 ITPR3 FANCA DOCK5 TARBP1 GOLGB1 GNL3L IPO8 COG7 RBM4 SACM1L TRIM67 EXOC1 EXOC2 | 2.61e-04 | 631 | 205 | 17 | int:BSG |
| Interaction | RHOD interactions | SLK MYO6 SPTB SPTBN1 MTMR1 EXOC3 SOWAHC ITPR3 STX5 SEMA6D TMTC3 FERMT2 GOLGB1 ANK3 MPZL1 CCDC88A | 2.62e-04 | 572 | 205 | 16 | int:RHOD |
| Interaction | NINL interactions | HAUS6 CNTLN BRCA1 CCDC138 SCLT1 CAMSAP2 CCHCR1 DCTN2 IFT74 BAG2 HAUS2 SPAG5 CEP55 SIPA1L1 | 2.63e-04 | 458 | 205 | 14 | int:NINL |
| Interaction | IFNA21 interactions | 2.64e-04 | 31 | 205 | 4 | int:IFNA21 | |
| Interaction | CALM2 interactions | 2.69e-04 | 206 | 205 | 9 | int:CALM2 | |
| Interaction | BRK1 interactions | 2.80e-04 | 124 | 205 | 7 | int:BRK1 | |
| Interaction | NDEL1 interactions | 2.82e-04 | 164 | 205 | 8 | int:NDEL1 | |
| Interaction | LCK interactions | MYO6 SPTBN1 EXOC3 STAT5A NF1 BRCA1 FERMT2 NOS2 GOLGA3 GOLGB1 ANK3 BAG2 CEP55 CCDC88A | 2.93e-04 | 463 | 205 | 14 | int:LCK |
| Interaction | PYDC2 interactions | 3.07e-04 | 3 | 205 | 2 | int:PYDC2 | |
| Interaction | SPMAP2L interactions | 3.07e-04 | 3 | 205 | 2 | int:SPMAP2L | |
| Interaction | FAM234A interactions | 3.09e-04 | 126 | 205 | 7 | int:FAM234A | |
| Interaction | NIN interactions | HAUS6 CCDC138 SCLT1 CAMSAP2 CCHCR1 DCTN2 IFT74 ISOC1 HAUS2 SPAG5 CEP55 SIPA1L1 | 3.26e-04 | 359 | 205 | 12 | int:NIN |
| Interaction | H2BC4 interactions | MYH10 MYH11 MAP1B PDCD4 FSIP2 AEBP1 DCTN2 IFT74 POLR2A SMARCC2 | 3.34e-04 | 259 | 205 | 10 | int:H2BC4 |
| Interaction | ETV5 interactions | 3.38e-04 | 33 | 205 | 4 | int:ETV5 | |
| Interaction | EXOC4 interactions | 3.44e-04 | 213 | 205 | 9 | int:EXOC4 | |
| Interaction | SNAPIN interactions | 3.45e-04 | 169 | 205 | 8 | int:SNAPIN | |
| Cytoband | 9p22 | 1.64e-11 | 25 | 209 | 7 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 6.38e-09 | 124 | 209 | 9 | chr9p21 | |
| GeneFamily | Interferons | 3.53e-09 | 32 | 137 | 7 | 598 | |
| GeneFamily | Cytochrome P450 family 3 | 2.32e-05 | 8 | 137 | 3 | 1002 | |
| GeneFamily | Exocyst complex | 3.46e-05 | 9 | 137 | 3 | 1055 | |
| GeneFamily | Myosin heavy chains | 1.81e-04 | 15 | 137 | 3 | 1098 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.02e-04 | 46 | 137 | 4 | 622 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 4.41e-04 | 20 | 137 | 3 | 736 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.17e-03 | 7 | 137 | 2 | 1113 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.17e-03 | 7 | 137 | 2 | 785 | |
| GeneFamily | HAUS augmin like complex | 1.55e-03 | 8 | 137 | 2 | 581 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.58e-03 | 181 | 137 | 6 | 694 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | CYP3A4 CYP3A5 RBM4 IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 | 1.42e-09 | 85 | 207 | 10 | MM684 |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.15e-08 | 39 | 207 | 7 | M41095 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 9.21e-08 | 29 | 207 | 6 | MM586 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BRIX1 PDS5B HAUS6 SLK MYH10 RAPGEF6 MYO6 VPS13C EXOC3 BRCA1 KIF15 SACS NIPBL GOLGB1 IFT74 ZNF407 SACM1L CEP55 CCDC88A EXOC1 | 2.95e-07 | 656 | 207 | 20 | M18979 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 2.05e-06 | 27 | 207 | 5 | M40935 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_UP | MYO1E VPS13C STAT5A ARMH3 DOP1B JADE2 TOM1 MADD CELF1 ATRNL1 | 4.24e-06 | 198 | 207 | 10 | M9245 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 6.38e-06 | 16 | 207 | 4 | M40964 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 9.96e-06 | 131 | 207 | 8 | MM1127 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | SLK SPTBN1 CEP120 RMND5A PCLO MPZL1 IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 MLH3 CCDC88A NKAIN3 | 1.79e-05 | 584 | 207 | 16 | MM1080 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SYCP2L RAPGEF6 MAP1B LYST FSIP2 SEMA6D SRGAP1 TLN2 ANKRD18A CAMSAP2 TARBP1 GOLGA3 DOP1B ANK3 KIF21A PCLO GRM1 CCDC141 CCDC88A TRIM67 AKAP9 CELF1 SMARCC2 | 2.36e-05 | 1106 | 207 | 23 | M39071 |
| Coexpression | GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN | 2.75e-05 | 196 | 207 | 9 | M7672 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 3.09e-05 | 199 | 207 | 9 | M5893 | |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP | 3.09e-05 | 199 | 207 | 9 | M3087 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 4.17e-05 | 80 | 207 | 6 | MM1229 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 4.17e-05 | 80 | 207 | 6 | MM646 | |
| Coexpression | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN | 6.17e-05 | 53 | 207 | 5 | M8077 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 6.69e-05 | 87 | 207 | 6 | MM652 | |
| Coexpression | ZHONG_PFC_C1_OPC | 1.23e-04 | 238 | 207 | 9 | M39096 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PDS5B UBR1 HAUS6 SLK RAPGEF6 SAMD9 VPS13C HIPK1 TRIP12 BIRC6 LYST PDCD4 STAT4 STAT5A STAT5B PRKD3 TRANK1 SACS NIPBL JADE2 ELP1 MED1 SACM1L CCDC88A AKAP9 CELF1 | 1.30e-04 | 1492 | 207 | 26 | M40023 |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 1.46e-04 | 34 | 207 | 4 | M41094 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B SLK MAP1B CENPF KDM4C TRIP12 PIK3R4 BRCA1 SACS FERMT2 CAMSAP2 NIPBL DOP1B SEMA5A MED1 MTAP AKAP9 SIPA1L1 | 1.65e-04 | 856 | 207 | 18 | M4500 |
| Coexpression | GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP | 1.74e-04 | 196 | 207 | 8 | M4532 | |
| Coexpression | RODWELL_AGING_KIDNEY_DN | 1.81e-04 | 148 | 207 | 7 | M5408 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN | 1.86e-04 | 198 | 207 | 8 | M3352 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G2_M | 1.86e-04 | 198 | 207 | 8 | M2077 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 1.93e-04 | 199 | 207 | 8 | M8974 | |
| Coexpression | GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN | 1.93e-04 | 199 | 207 | 8 | M6507 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP | 1.93e-04 | 199 | 207 | 8 | M9238 | |
| Coexpression | GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP | 2.00e-04 | 200 | 207 | 8 | M9447 | |
| Coexpression | GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 2.00e-04 | 200 | 207 | 8 | M9392 | |
| Coexpression | GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN | 2.00e-04 | 200 | 207 | 8 | M9028 | |
| Coexpression | GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN | 2.00e-04 | 200 | 207 | 8 | M6966 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | BRIX1 PDS5B HAUS6 SLK MYH10 RAPGEF6 CENPF SOWAHC PRKD3 TMTC3 KIF15 SACS CCDC138 FERMT2 SPAG5 SACM1L ORC4 CELF1 | 2.22e-04 | 877 | 207 | 18 | M2241 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | MAP1B TRIP12 STAT5B SRGAP1 TLN2 FERMT2 CAMSAP2 RMND5A IPO8 ANK3 SEMA5A HAUS2 SPAG5 SEMA3D AKAP9 CELF1 SUPT16H | 5.86e-08 | 369 | 195 | 17 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CENPF SOWAHC BRCA1 KIF15 SRGAP1 NIPBL IFT74 SPAG5 WDR19 CCDC88A MTAP AKAP9 SUPT16H FGD6 | 1.19e-06 | 311 | 195 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | ZNF717 MYH11 MAP1B SIX4 TRIP12 STAT5A STAT5B SRGAP1 TLN2 FERMT2 CAMSAP2 RMND5A IPO8 ANK3 SEMA5A HAUS2 SPAG5 SEMA3D AKAP9 CELF1 SUPT16H PDE5A EXOC2 | 1.51e-06 | 806 | 195 | 23 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | HAUS6 MYH10 CENPF HIPK1 CNTLN SIX4 SOWAHC PRKD3 CEP120 KIF15 SCLT1 NIPBL IFT74 KIF21A POLR2A KLC2 SEMA5A MMRN1 RANBP17 CCDC88A MTAP AKAP9 MYH14 SUPT16H SMARCC2 UBR3 ZNF761 NKAIN3 FGD6 | 4.01e-06 | 1252 | 195 | 29 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | PDS5B HAUS6 SLK RAPGEF6 PIK3R4 CEP120 GOLGB1 GNL3L HYKK RBM4B POLR2A COP1 ISOC1 ZNF407 SPAG5 EXOC2 FGD6 | 1.90e-05 | 564 | 195 | 17 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | PDS5B UBR1 SLK MYH10 CENPF CNTLN SCLT1 NIPBL GOLGB1 RBM4B KIF21A POLR2A COP1 ISOC1 ZNF407 AKAP9 SMARCC2 UBR3 | 2.14e-05 | 629 | 195 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MAP1B CENPF HIPK1 SLC22A23 SOWAHC BRCA1 KIF15 SRGAP1 ARMH3 NIPBL GOLGA3 IFT74 KIF21A PCLO DHX57 SPAG5 WDR19 CCDC88A AKAP9 CGRRF1 SUPT16H | 2.77e-05 | 831 | 195 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | MAP1B BIRC6 STAT5B FERMT2 CAMSAP2 ALK RMND5A IPO8 ANK3 SEMA5A MED1 HAUS2 AKAP9 | 6.02e-05 | 385 | 195 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 7.97e-05 | 194 | 195 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | CENPF BRCA1 SRGAP1 NIPBL RBM4B DHX57 WDR19 CCDC88A AKAP9 SUPT16H FGD6 | 8.32e-05 | 291 | 195 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | MYH10 HPSE2 CNTLN FMN1 PLA2G4A SCLT1 NIPBL GOLGB1 CCDC88A MYH14 FGD6 | 1.03e-04 | 298 | 195 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | HAUS6 MAP1B CENPF VPS13C SLC22A23 BIRC6 BRCA1 KIF15 SCLT1 FERMT2 NIPBL KIF21A PCLO SPAG5 SUPT16H | 1.25e-04 | 532 | 195 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | HAUS6 MYH10 CENPF HIC2 CNTLN SOWAHC CEP120 BRCA1 KIF15 CCDC138 SCLT1 NIPBL GNL3L IPO8 IFT74 KIF21A SPAG5 ORC4 CCDC88A MTAP AKAP9 MYH14 SUPT16H ZNF761 NKAIN3 | 2.26e-04 | 1257 | 195 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | ADAD1 CENPF TRANK1 BRCA1 FTHL17 CCDC138 CCDC73 CCDC150 RANBP17 DDX25 PDE5A FGD6 | 2.43e-04 | 385 | 195 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | SYCP2L HAUS6 MAP1B CENPF VPS13C MTMR1 CNTLN FANCA BRCA1 KIF15 KIF21A PCLO PTPRU MADD SPAG5 CEP55 WDR19 SEMA3D MTAP AKAP9 UBR3 | 2.90e-04 | 983 | 195 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 2.90e-04 | 98 | 195 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | MAP1B CENPF SLC22A23 CNTLN BRCA1 KIF15 CCDC138 SCLT1 NIPBL CCHCR1 IPO8 IFT74 KIF21A KLC2 MADD SPAG5 RANBP17 CCDC88A AKAP9 MYH14 SUPT16H NKAIN3 | 3.08e-04 | 1060 | 195 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SYCP2L MAP1B CENPF SLC22A23 SOWAHC BRCA1 KIF15 SRGAP1 NIPBL IFT74 KIF21A PCLO SPAG5 CEP55 WDR19 ORC4 CCDC88A MTAP AKAP9 SUPT16H FGD6 | 3.14e-04 | 989 | 195 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.44e-04 | 187 | 195 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SYCP2L HAUS6 MYH10 MAP1B CENPF HIC2 CNTLN SOWAHC CEP120 BRCA1 KIF15 CCDC138 SCLT1 NIPBL GNL3L IPO8 IFT74 KIF21A SPAG5 ORC4 CCDC88A MTAP AKAP9 MYH14 SUPT16H ZNF761 NKAIN3 | 3.94e-04 | 1459 | 195 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | MYH11 MAP1B STAT5A SRGAP1 TLN2 FERMT2 ANK3 SEMA5A SEMA3D CELF1 SUPT16H PDE5A | 4.10e-04 | 408 | 195 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.11e-04 | 192 | 195 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.11e-04 | 192 | 195 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 4.33e-04 | 69 | 195 | 5 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_500 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | SLK MYO6 ABCA13 SPTBN1 TMTC3 GOLGB1 ANK3 KIF21A PCLO AKAP9 MYH14 | 3.01e-09 | 200 | 209 | 11 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | SLK MYO6 ABCA13 GOLGB1 ANK3 KIF21A PCLO MUC16 CCDC80 AKAP9 MYH14 | 3.01e-09 | 200 | 209 | 11 | ecbe89ff95d046155b984c8c150e0b9e7278f839 |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | MYH10 MYH11 MAP1B TMTC3 SRGAP1 MPZL1 CCDC141 TRIM67 CCDC42 PDE5A | 1.88e-08 | 185 | 209 | 10 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-07 | 195 | 209 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 4.08e-07 | 197 | 209 | 9 | a05237ee6d31d9eab491dd7007859d6285cf1424 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.26e-07 | 198 | 209 | 9 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | SAMD9 VPS13C TRIP12 ANKRD18A NIPBL GOLGB1 BBOF1 KIF21A AKAP9 | 4.44e-07 | 199 | 209 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.63e-07 | 200 | 209 | 9 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.63e-07 | 156 | 209 | 8 | 8349604bd801e20d33770f7d8243598c3756302b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-06 | 167 | 209 | 8 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.66e-06 | 173 | 209 | 8 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-06 | 177 | 209 | 8 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-06 | 180 | 209 | 8 | eb5a57604c7f2ad256c300085dbf5069d0ae1ad0 | |
| ToppCell | 368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-06 | 180 | 209 | 8 | ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-06 | 182 | 209 | 8 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-06 | 188 | 209 | 8 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-06 | 188 | 209 | 8 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.09e-06 | 188 | 209 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-06 | 188 | 209 | 8 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-06 | 189 | 209 | 8 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.34e-06 | 190 | 209 | 8 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.61e-06 | 192 | 209 | 8 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.61e-06 | 192 | 209 | 8 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.61e-06 | 192 | 209 | 8 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-06 | 193 | 209 | 8 | 9a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.75e-06 | 193 | 209 | 8 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.75e-06 | 193 | 209 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-06 | 193 | 209 | 8 | 7c7aa5e2124830d0fa1df11b6413ec6cf780aad0 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.89e-06 | 194 | 209 | 8 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-06 | 195 | 209 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.04e-06 | 195 | 209 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-06 | 196 | 209 | 8 | 5159d8625d80c20eb28157b2603c8bde9d377a35 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-06 | 196 | 209 | 8 | 6b5b7dbcb2cce8a736e44145a01290905876a5e9 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-06 | 197 | 209 | 8 | 789c97ca9d1e28df3353140046047f11fbccc1d0 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.36e-06 | 197 | 209 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.53e-06 | 198 | 209 | 8 | e9f434bfd072e590fe44d518057ee5aa653038f3 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.53e-06 | 198 | 209 | 8 | dc0c6189ff9dd76675f63acf1cbc7dda60e75f3f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.53e-06 | 198 | 209 | 8 | 50f236ab7ef6f00721f6cd714e3eee183077beeb | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.70e-06 | 199 | 209 | 8 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.87e-06 | 200 | 209 | 8 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-06 | 200 | 209 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 4.87e-06 | 200 | 209 | 8 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | 5'-Airway_Nasal-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-06 | 200 | 209 | 8 | 358d71329921451c7f5a56f1db0f9989af2299dc | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.87e-06 | 200 | 209 | 8 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | Nasal_Brush-Epithelial|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.87e-06 | 200 | 209 | 8 | 7911073119ee47a37b68b73fc54f063e902a5067 | |
| ToppCell | 5'-Airway_Nasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-06 | 200 | 209 | 8 | f6e967738b4f7b173d6e9977e305f77380dd6c8a | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.87e-06 | 200 | 209 | 8 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | (24)_B_cell_cycling|World / shred on Cell_type and subtype | 5.24e-06 | 202 | 209 | 8 | a7c9b6b173701348ba35fbb975e0bdd3c1f1d5fe | |
| ToppCell | Pericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 7.08e-06 | 150 | 209 | 7 | dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 9.15e-06 | 156 | 209 | 7 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 161 | 209 | 7 | ed93cb6c133855a5c244821e1a260aae8ab4df9a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-05 | 161 | 209 | 7 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 161 | 209 | 7 | 0089d7bb305c592392791862a3341fc92af8f3e2 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.37e-05 | 166 | 209 | 7 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 166 | 209 | 7 | 2642544070564debe2deb2938d2c33997bf5ef02 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.37e-05 | 166 | 209 | 7 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.43e-05 | 167 | 209 | 7 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 168 | 209 | 7 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 168 | 209 | 7 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.48e-05 | 168 | 209 | 7 | 53a982869dbf14f6a948589be9f2f3df3b9a7e97 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.48e-05 | 168 | 209 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 168 | 209 | 7 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.60e-05 | 170 | 209 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.79e-05 | 173 | 209 | 7 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.86e-05 | 174 | 209 | 7 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-05 | 176 | 209 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 177 | 209 | 7 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 177 | 209 | 7 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 177 | 209 | 7 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-05 | 178 | 209 | 7 | 829ea00c022a78d1861aa3ec53503272976775d9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-05 | 179 | 209 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.23e-05 | 179 | 209 | 7 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-05 | 180 | 209 | 7 | 1c1b25f1d22518db5469707131510daae84716a3 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 2.39e-05 | 181 | 209 | 7 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-05 | 182 | 209 | 7 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.57e-05 | 183 | 209 | 7 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-05 | 183 | 209 | 7 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 184 | 209 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 184 | 209 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 184 | 209 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-05 | 184 | 209 | 7 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-05 | 185 | 209 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.75e-05 | 185 | 209 | 7 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.75e-05 | 185 | 209 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 185 | 209 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-05 | 186 | 209 | 7 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 186 | 209 | 7 | aa88d9573a237b2b8e6025fee31f69fbce824497 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 186 | 209 | 7 | ecc5acd111a6ee50d59544d1bdd7ed94e2812aae | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-05 | 186 | 209 | 7 | 26458ff8cad5577de4306cffa0ca69eb26940e0d | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 186 | 209 | 7 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-05 | 186 | 209 | 7 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue | 2.85e-05 | 186 | 209 | 7 | e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-05 | 186 | 209 | 7 | a71397efc68d2916ddc373d92cfd07be58033e1c | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 186 | 209 | 7 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.95e-05 | 187 | 209 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 3.05e-05 | 188 | 209 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | ASK454-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.16e-05 | 189 | 209 | 7 | 316c857dec9383823e09f966bca62d52d933b141 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.27e-05 | 190 | 209 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 3.27e-05 | 190 | 209 | 7 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.27e-05 | 190 | 209 | 7 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| Drug | Yfrkd | 1.25e-09 | 7 | 208 | 5 | CID000129984 | |
| Drug | 1hiv | 3.32e-09 | 8 | 208 | 5 | CID005479205 | |
| Drug | Chebi:36708 | 3.32e-09 | 8 | 208 | 5 | CID011966289 | |
| Drug | Nyco | 9.16e-09 | 18 | 208 | 6 | CID000071618 | |
| Drug | pipobroman | 1.47e-08 | 10 | 208 | 5 | CID000004842 | |
| Drug | val-mCyd | 1.88e-08 | 20 | 208 | 6 | CID006918726 | |
| Drug | flesinoxan | 2.68e-08 | 11 | 208 | 5 | CID000057347 | |
| Drug | leukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA | PDS5B CENPF VPS13C MTMR1 EXOC3 PLXND1 SOWAHC PDCD4 DOP1B BAG2 ISOC1 SMARCC2 FGD6 | 3.11e-08 | 195 | 208 | 13 | 1108_UP |
| Drug | AC1L1U53 | 7.22e-08 | 60 | 208 | 8 | CID000060907 | |
| Drug | R 842 | 7.35e-08 | 13 | 208 | 5 | CID000130714 | |
| Drug | AC1O52EF | 7.35e-08 | 13 | 208 | 5 | CID006450817 | |
| Drug | hycanthone | 8.29e-08 | 25 | 208 | 6 | CID000003634 | |
| Drug | LB80380 | 8.29e-08 | 25 | 208 | 6 | CID006480442 | |
| Drug | ABMP | 1.07e-07 | 26 | 208 | 6 | CID000080567 | |
| Drug | Lanicemine | 1.14e-07 | 14 | 208 | 5 | CID003038485 | |
| Drug | gunacin | 1.14e-07 | 14 | 208 | 5 | CID000198547 | |
| Drug | pppA2'-5'A2'-5'A | 1.69e-07 | 15 | 208 | 5 | CID000125229 | |
| Drug | NM 108 | 2.16e-07 | 29 | 208 | 6 | CID000500901 | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; PC3; HT_HG-U133A | PDS5B CDK16 SLK MYH10 DIPK1A NF1 TGFBRAP1 FERMT2 DOP1B MADD WDR19 CELF1 | 2.84e-07 | 197 | 208 | 12 | 7138_DN |
| Drug | YNK01 | 3.43e-07 | 17 | 208 | 5 | CID000084071 | |
| Drug | imidazoquinoline | 3.77e-07 | 101 | 208 | 9 | CID005351568 | |
| Drug | CHEMBL466993 | 4.02e-07 | 32 | 208 | 6 | CID005320808 | |
| Drug | famciclovir | 4.53e-07 | 52 | 208 | 7 | CID000003324 | |
| Drug | p203 | 4.72e-07 | 18 | 208 | 5 | CID000019228 | |
| Drug | podophyllin | 4.72e-07 | 18 | 208 | 5 | CID011979494 | |
| Drug | tenofovir disoproxil fumarate | 5.88e-07 | 34 | 208 | 6 | CID005481350 | |
| Drug | tilorone | 7.04e-07 | 35 | 208 | 6 | CID000005475 | |
| Drug | Beryllium | 7.62e-07 | 56 | 208 | 7 | CID000107649 | |
| Drug | Ciluprevir [USAN] | 8.41e-07 | 20 | 208 | 5 | CID006450803 | |
| Drug | rosuvastatin | 1.10e-06 | 59 | 208 | 7 | CID000446157 | |
| Drug | L DO | 1.10e-06 | 21 | 208 | 5 | CID000097725 | |
| Drug | isofagomine lactam | 1.37e-06 | 39 | 208 | 6 | CID000448980 | |
| Drug | formosanin C | 1.41e-06 | 22 | 208 | 5 | CID000073597 | |
| Drug | Hiltonol | 1.78e-06 | 23 | 208 | 5 | CID000431963 | |
| Drug | 1 ind | 2.16e-06 | 42 | 208 | 6 | CID003037877 | |
| Drug | PHA-00816795 [212631-79-3]; Down 200; 10uM; PC3; HT_HG-U133A | CENPF DIPK1A HIPK1 SPTBN1 MTMR1 PLXND1 NF1 SEMA5A PTPRU MED1 MTAP | 2.22e-06 | 198 | 208 | 11 | 7076_DN |
| Drug | diclofenac sodium; Up 200; 10uM; MCF7; HG-U133A | CYP3A7 CLTCL1 EXOC3 PLXND1 PDCD4 TLN2 NIPBL MED1 CCDC7 SIPA1L1 IL1RL1 | 2.22e-06 | 198 | 208 | 11 | 333_UP |
| Drug | AC1L1ZCT | 2.24e-06 | 24 | 208 | 5 | CID000038235 | |
| Drug | cycloferon | 2.24e-06 | 24 | 208 | 5 | CID000038072 | |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; MCF7; HT_HG-U133A | CENPF MTMR1 HIC2 ITPR3 NF1 NOS2 RMND5A USP29 GRM1 CCDC88A ATRNL1 | 2.44e-06 | 200 | 208 | 11 | 5454_UP |
| Drug | temozolomide | 2.61e-06 | 127 | 208 | 9 | CID000005394 | |
| Drug | barium iodide | 2.99e-06 | 4 | 208 | 3 | CID000083684 | |
| Drug | Solvent Yellow-?14 | 3.74e-06 | 46 | 208 | 6 | CID005354458 | |
| Drug | poly(I-C | 4.10e-06 | 171 | 208 | 10 | CID000213546 | |
| Drug | inosiplex | 4.16e-06 | 27 | 208 | 5 | CID000037510 | |
| Drug | VX-497 | 4.16e-06 | 27 | 208 | 5 | CID000153241 | |
| Drug | AC1NRD2B | 5.02e-06 | 28 | 208 | 5 | CID005289317 | |
| Drug | apropovir | 5.45e-06 | 49 | 208 | 6 | CID000064987 | |
| Drug | adefovir dipivoxil | 5.45e-06 | 49 | 208 | 6 | CID000060871 | |
| Drug | NSC141633 | 6.02e-06 | 29 | 208 | 5 | CID000003628 | |
| Drug | 1 Jak | 6.15e-06 | 76 | 208 | 7 | CID000446429 | |
| Drug | 2',3'-dideoxycytidine (ddC | 6.15e-06 | 76 | 208 | 7 | CID000005718 | |
| Drug | nifedipine | CYP3A7 MYH10 MYH11 CYP2J2 MYO6 CYP3A4 CYP3A5 BIRC6 HEPH ITIH4 ITPR3 PRKD3 NOS2 GRM1 MYH14 | 6.97e-06 | 415 | 208 | 15 | CID000004485 |
| Drug | penciclovir | 7.18e-06 | 30 | 208 | 5 | CID000004725 | |
| Drug | DZNep | 7.18e-06 | 30 | 208 | 5 | CID000073087 | |
| Drug | poly rI:rC | 7.18e-06 | 30 | 208 | 5 | CID011979660 | |
| Drug | mu-I | 7.32e-06 | 78 | 208 | 7 | CID011987863 | |
| Drug | B132 | 7.41e-06 | 5 | 208 | 3 | CID002734031 | |
| Drug | SAHA; Up 200; 10uM; HL60; HT_HG-U133A | MYH10 MYO6 DIPK1A BBS1 ATG2A CAMSAP2 PCLO MPZL1 WDR19 CGRRF1 | 7.48e-06 | 183 | 208 | 10 | 6179_UP |
| Drug | Zinetac | 8.67e-06 | 80 | 208 | 7 | CID000005039 | |
| Drug | lomustine | 9.99e-06 | 32 | 208 | 5 | CID000003950 | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | MYH10 MAP1B MYO6 LYST FERMT2 GNL3L RBM4 SEMA5A HAUS2 CCDC88A | 1.09e-05 | 191 | 208 | 10 | 4283_DN |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | MAP1B PLXND1 LYST DOCK5 DOP1B RMND5A ELP1 GRM1 SIPA1L1 LRRC8B | 1.09e-05 | 191 | 208 | 10 | 6776_UP |
| Drug | 2-hydroxyisovaleric acid | 1.20e-05 | 56 | 208 | 6 | CID000099823 | |
| Drug | m IU | 1.20e-05 | 56 | 208 | 6 | CID006852123 | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; HL60; HG-U133A | 1.25e-05 | 194 | 208 | 10 | 1552_DN | |
| Drug | diosmetin | 1.30e-05 | 85 | 208 | 7 | CID005281612 | |
| Drug | carprofen | 1.36e-05 | 34 | 208 | 5 | CID000002581 | |
| Drug | oxymatrine | 1.36e-05 | 34 | 208 | 5 | CID000114850 | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | SOWAHC LYST STAT5B DOCK5 NF1 IPO8 ELP1 WDR19 SIPA1L1 SMARCC2 | 1.36e-05 | 196 | 208 | 10 | 5341_UP |
| Drug | HCV-371 | 1.47e-05 | 6 | 208 | 3 | CID003013096 | |
| Drug | Alfentanil | 1.47e-05 | 6 | 208 | 3 | ctd:D015760 | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.56e-05 | 199 | 208 | 10 | 7133_DN | |
| Drug | lobucavir | 1.58e-05 | 35 | 208 | 5 | CID000060786 | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; PC3; HT_HG-U133A | CENPF DIPK1A VPS13C TCP11L1 PDCD4 NF1 BRCA1 DOP1B IPPK AKAP9 | 1.62e-05 | 200 | 208 | 10 | 7151_DN |
| Drug | MCNU | 1.82e-05 | 36 | 208 | 5 | CID000071741 | |
| Drug | A809128 | 1.82e-05 | 36 | 208 | 5 | CID003392279 | |
| Drug | Azamulinum | 1.87e-05 | 18 | 208 | 4 | CID003086060 | |
| Drug | acyclovir | 1.89e-05 | 124 | 208 | 8 | CID000002022 | |
| Drug | dipyridamole | 1.89e-05 | 162 | 208 | 9 | CID000003108 | |
| Drug | pyran | 2.08e-05 | 37 | 208 | 5 | CID000033703 | |
| Drug | FMAU | 2.08e-05 | 37 | 208 | 5 | CID000072327 | |
| Drug | methimazole | 2.12e-05 | 126 | 208 | 8 | CID001349907 | |
| Drug | anagrelide | 2.38e-05 | 38 | 208 | 5 | CID000002182 | |
| Drug | fotemustine | 2.38e-05 | 38 | 208 | 5 | CID000104799 | |
| Drug | NMMA | 2.51e-05 | 94 | 208 | 7 | CID000170607 | |
| Drug | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | 2.58e-05 | 211 | 208 | 10 | ctd:C009618 | |
| Drug | Azitidin | 2.64e-05 | 169 | 208 | 9 | CID000005726 | |
| Drug | sunitinib | 2.65e-05 | 130 | 208 | 8 | CID005329102 | |
| Drug | leucovorin | 2.65e-05 | 130 | 208 | 8 | CID000000143 | |
| Drug | rifampicin | CYP3A7 CYP2J2 CYP3A4 CYP3A5 LYST NOS2 POLR2A IFNA4 IFNA5 IFNA7 IFNA10 IFNA17 | 2.67e-05 | 306 | 208 | 12 | CID005381226 |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 2.89e-05 | 171 | 208 | 9 | 7535_DN | |
| Drug | imiquimod | 2.96e-05 | 132 | 208 | 8 | CID000057469 | |
| Drug | AC1O51IP | 3.11e-05 | 66 | 208 | 6 | CID006450363 | |
| Drug | copolymer 1 | 3.11e-05 | 66 | 208 | 6 | CID003081884 | |
| Drug | AC1L40MO | 3.13e-05 | 133 | 208 | 8 | CID000099067 | |
| Drug | halothane | CYP3A7 CYP2J2 CYP3A4 CYP3A5 ITPR3 PRKD3 NOS2 IFNA4 IFNA5 IFNA7 IFNA10 IFNA17 | 3.43e-05 | 314 | 208 | 12 | CID000003562 |
| Drug | vindesine | 3.69e-05 | 68 | 208 | 6 | CID000040839 | |
| Drug | MeSAdo | 3.87e-05 | 137 | 208 | 8 | CID000000149 | |
| Drug | methylenedinitramine | 3.92e-05 | 42 | 208 | 5 | CID000026524 | |
| Disease | tacrolimus measurement | 1.20e-06 | 4 | 199 | 3 | EFO_0008458 | |
| Disease | androsterone sulfate measurement | 7.05e-05 | 33 | 199 | 4 | EFO_0021117 | |
| Disease | Malignant neoplasm of breast | CENPF CYP3A4 SIX4 PDCD4 STAT4 STAT5A PIK3R4 TAS2R13 STX5 NF1 BRCA1 PLA2G4A NOS2 NIPBL ALK GOLGB1 ELP1 AKAP9 SIPA1L1 | 1.31e-04 | 1074 | 199 | 19 | C0006142 |
| Disease | pulse pressure measurement | HAUS6 MYH11 MYO1E MAP1B STAT5B PIK3R4 PRKD3 TRANK1 CEP120 KIF15 PRPF40B PSORS1C1 TLN2 FERMT2 ARMH3 TRAF7 MEI1 CCDC141 MADD CELF1 UBR3 FGD6 | 1.92e-04 | 1392 | 199 | 22 | EFO_0005763 |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 2.69e-04 | 4 | 199 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | estrone conjugate measurement | 2.69e-04 | 4 | 199 | 2 | EFO_0007971 | |
| Disease | metabolonic lactone sulfate measurement | 2.70e-04 | 19 | 199 | 3 | EFO_0800659 | |
| Disease | tauro-beta-muricholate measurement | 4.47e-04 | 5 | 199 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 4.47e-04 | 5 | 199 | 2 | EFO_0800569 | |
| Disease | ovarian cancer (is_implicated_in) | 5.60e-04 | 56 | 199 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | epiandrosterone sulfate measurement | 6.23e-04 | 25 | 199 | 3 | EFO_0021120 | |
| Disease | age at diagnosis, substance-related disorder | 6.67e-04 | 6 | 199 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 6.67e-04 | 6 | 199 | 2 | EFO_0021119 | |
| Disease | Curling Ulcer | 6.67e-04 | 6 | 199 | 2 | C0010474 | |
| Disease | Duodenal Ulcer | 6.67e-04 | 6 | 199 | 2 | C0013295 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 6.67e-04 | 6 | 199 | 2 | EFO_0800294 | |
| Disease | Hyalinosis, Segmental Glomerular | 8.74e-04 | 28 | 199 | 3 | C0086432 | |
| Disease | estradiol measurement | 9.16e-04 | 110 | 199 | 5 | EFO_0004697 | |
| Disease | heroin dependence | 9.29e-04 | 7 | 199 | 2 | EFO_0004240 | |
| Disease | X-24574 measurement | 9.29e-04 | 7 | 199 | 2 | EFO_0800897 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 9.29e-04 | 7 | 199 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | Periventricular Nodular Heterotopia | 9.29e-04 | 7 | 199 | 2 | C1868720 | |
| Disease | multiple myeloma | 9.93e-04 | 112 | 199 | 5 | EFO_0001378 | |
| Disease | central nervous system cancer | 1.18e-03 | 31 | 199 | 3 | EFO_0000326 | |
| Disease | intelligence, self reported educational attainment | 1.21e-03 | 117 | 199 | 5 | EFO_0004337, EFO_0004784 | |
| Disease | Intestinal Diseases | 1.23e-03 | 8 | 199 | 2 | C0021831 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 1.30e-03 | 70 | 199 | 4 | EFO_0008082 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 1.58e-03 | 9 | 199 | 2 | EFO_0800278 | |
| Disease | smoking cessation | 1.71e-03 | 325 | 199 | 8 | EFO_0004319 | |
| Disease | Focal glomerulosclerosis | 1.83e-03 | 36 | 199 | 3 | C0017668 | |
| Disease | gamma-glutamylthreonine measurement | 1.97e-03 | 10 | 199 | 2 | EFO_0021143 | |
| Disease | uremia (biomarker_via_orthology) | 1.97e-03 | 10 | 199 | 2 | DOID:4676 (biomarker_via_orthology) | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.97e-03 | 10 | 199 | 2 | EFO_0022090 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 1.97e-03 | 10 | 199 | 2 | EFO_0800289 | |
| Disease | Fanconi anemia (is_implicated_in) | 1.97e-03 | 10 | 199 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | allergic rhinitis | 2.12e-03 | 133 | 199 | 5 | EFO_0005854 | |
| Disease | amino acid measurement | MYH10 CLTCL1 MYO1E CYP2J2 FMN1 PLA2G4A ALK COG7 SEMA5A GRM1 MMRN1 CCDC42 | 2.30e-03 | 678 | 199 | 12 | EFO_0005134 |
| Disease | Jeune thoracic dystrophy | 2.39e-03 | 11 | 199 | 2 | C0265275 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 2.39e-03 | 11 | 199 | 2 | EFO_0801531 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 2.39e-03 | 11 | 199 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 2.39e-03 | 11 | 199 | 2 | EFO_0800295 | |
| Disease | neuroimaging measurement | MYH10 SAMD9 MAP1B SPTBN1 PFDN1 PLXND1 NF1 BRCA1 TLN2 ANK3 SEMA3D CCDC88A CELF1 EXOC2 FGD6 DNAH11 | 2.53e-03 | 1069 | 199 | 16 | EFO_0004346 |
| Disease | Combined immunodeficiency | 2.67e-03 | 41 | 199 | 3 | C0494261 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 2.86e-03 | 12 | 199 | 2 | C0403553 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 2.86e-03 | 12 | 199 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | response to carboplatin, methylcobalamin deficiency type cblE, response to antineoplastic agent | 2.86e-03 | 12 | 199 | 2 | GO_0097327, GO_0097328, MONDO_0009354 | |
| Disease | Essential Hypertension | 2.86e-03 | 12 | 199 | 2 | C0085580 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 2.86e-03 | 12 | 199 | 2 | EFO_0800291 | |
| Disease | autistic disorder (is_implicated_in) | 2.86e-03 | 42 | 199 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | lobe attachment | 2.89e-03 | 207 | 199 | 6 | EFO_0007667 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 3.06e-03 | 43 | 199 | 3 | EFO_0004471, EFO_0006896 | |
| Disease | rosacea severity measurement | 3.27e-03 | 147 | 199 | 5 | EFO_0009180 | |
| Disease | hemorrhoid | 3.27e-03 | 147 | 199 | 5 | EFO_0009552 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 3.36e-03 | 13 | 199 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 3.36e-03 | 13 | 199 | 2 | EFO_0800284 | |
| Disease | pre-eclampsia (implicated_via_orthology) | 3.36e-03 | 13 | 199 | 2 | DOID:10591 (implicated_via_orthology) | |
| Disease | interleukin 17 measurement | 3.48e-03 | 45 | 199 | 3 | EFO_0008174 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 3.48e-03 | 45 | 199 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Intellectual Disability | 3.49e-03 | 447 | 199 | 9 | C3714756 | |
| Disease | atrial fibrillation | 3.85e-03 | 371 | 199 | 8 | EFO_0000275 | |
| Disease | multiple myeloma, monoclonal gammopathy | 3.90e-03 | 14 | 199 | 2 | EFO_0000203, EFO_0001378 | |
| Disease | X-21470 measurement | 3.90e-03 | 14 | 199 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 3.90e-03 | 14 | 199 | 2 | EFO_0800283 | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 3.90e-03 | 14 | 199 | 2 | DOID:874 (biomarker_via_orthology) | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 4.49e-03 | 15 | 199 | 2 | EFO_0800301 | |
| Disease | Weight Gain | 5.10e-03 | 102 | 199 | 4 | C0043094 | |
| Disease | vision disorder | 5.10e-03 | 16 | 199 | 2 | MONDO_0021084 | |
| Disease | X-21410 measurement | 5.10e-03 | 16 | 199 | 2 | EFO_0800813 | |
| Disease | T-Cell Lymphoma | 5.10e-03 | 16 | 199 | 2 | C0079772 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 5.10e-03 | 16 | 199 | 2 | EFO_0800305 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis | 5.76e-03 | 17 | 199 | 2 | EFO_0004276, EFO_0004775 | |
| Disease | Alzheimer disease | 5.89e-03 | 485 | 199 | 9 | MONDO_0004975 | |
| Disease | nevus count | 6.45e-03 | 18 | 199 | 2 | EFO_0004632 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 6.45e-03 | 18 | 199 | 2 | EFO_0800288 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSFETDQVLLQHMKD | 371 | P59817 | |
| SHAAQLQILMEFLKV | 256 | Q8NHY2 | |
| DFQENMHTLLNKVTE | 1251 | Q99996 | |
| HAATLVMKLQLFIQE | 36 | P83436 | |
| VMKLQLFIQEVNHAV | 41 | P83436 | |
| HMVEFLLKNQANIHA | 181 | Q8IVF6 | |
| MLQFSEFHEKLLNTL | 1321 | Q9NR09 | |
| LVLEHQDSVSKLEMQ | 791 | Q96M83 | |
| LNHSIKVMSNVFENL | 846 | Q9NXG0 | |
| LIKEALIHMDQNFGN | 96 | P51589 | |
| ENNKEALLTFMEQVH | 891 | Q8IUX7 | |
| AALEAQNALHNMKVL | 71 | Q92879 | |
| KHRLDFLQLMIDSQN | 266 | P20815 | |
| MESAFHLEKNVNQSL | 101 | Q9BXU8 | |
| DIQANLIMKRHFTQA | 851 | Q8NB90 | |
| KQQHDLMETVNNLLT | 246 | O15123 | |
| HMVEFLLKNQANIHA | 181 | A2A2Z9 | |
| NSSINNIHEMEIQLK | 161 | Q53EZ4 | |
| HDNFTKNLENLMSTI | 136 | Q4W4Y0 | |
| KLHFEQMVRQSTLEL | 2131 | Q96DT5 | |
| HQGLKFMQDLFNALL | 2356 | Q86UQ4 | |
| FLVQNIHTLAELKMT | 141 | Q8TDN6 | |
| LHQFAQMQRVQLDLK | 101 | Q96M93 | |
| FLLAVHEQKQQMEDF | 186 | Q6NSI1 | |
| FLMSNETVLLAKHNI | 506 | Q5T2E6 | |
| AQETLEHNLALAKMV | 3371 | Q96M86 | |
| ALEDTHKQLDMIQQF | 281 | Q96M95 | |
| IKQLHEQAMQFGQLL | 336 | Q13561 | |
| FESEVLKLQQHAMIE | 306 | Q8ND07 | |
| SLQFLQQQHSEMLAK | 56 | Q96AQ1 | |
| SLQFLQQQHSEMLAK | 56 | Q96LY2 | |
| FQFNQHLMDSLSLKI | 581 | Q8IWY9 | |
| LMKIQDHFNSSIKQL | 456 | Q9UHL0 | |
| LMEIQLSKVSFQHEV | 1481 | Q2TAZ0 | |
| VNNSTMKIDHFQLDN | 666 | Q76M96 | |
| MAHFKDDLQTNVEII | 1 | Q5TC04 | |
| LLNNLMTHQNVELFK | 236 | Q96IK5 | |
| MTHQNVELFKELSIN | 241 | Q96IK5 | |
| QQLVKHLQMDIHIFE | 166 | Q14624 | |
| TIMDANAQSHKLIIF | 326 | Q13613 | |
| DNHFDNVLQAFVKML | 856 | Q9H2T7 | |
| LDNTEFQGKRMHVQL | 131 | Q9BWF3 | |
| EILMAKNENNSHAFI | 1026 | Q9NTI5 | |
| TLHNLKNMAQFSVLL | 266 | Q13126 | |
| LHLEMKDIQQAIFNV | 1066 | Q68DA7 | |
| QRMHFALKSLLQEAQ | 191 | Q9H8X2 | |
| DVVLLQKLQHAAQME | 86 | Q14573 | |
| QEAMHTFKQVQLLIS | 1086 | Q14573 | |
| VSHLTAQLNELKEQM | 2636 | Q14573 | |
| QEKLNHQLEGLTFQM | 231 | P06727 | |
| ERQTLIQHFQAMVKA | 426 | Q06481 | |
| AVLHSFQKQNVTIMD | 421 | P35228 | |
| VVMKAFEHLQQLELI | 371 | O43929 | |
| SLKFNITDNVMQHLL | 13946 | Q8WXI7 | |
| FQKAQAISVLHEMIQ | 71 | P01566 | |
| DLQVCKHLFIQMLQI | 181 | Q8N8D7 | |
| QIDMHRKFVVQLFAE | 61 | Q96CN7 | |
| TLQSMNNHLEAVLKE | 91 | Q9NVX0 | |
| INLKFMHNQVFIELN | 1566 | Q8WXG6 | |
| THEKQQDLNIMVLAS | 2436 | P46821 | |
| EFNKLSERHMHVQLQ | 831 | Q9NS87 | |
| KNHTCLVFEMLEQNL | 261 | Q86Z02 | |
| LQMFEDLHIQESKIN | 561 | Q13201 | |
| FVQLHKLVRLDMTSN | 206 | Q9P244 | |
| INHSQSLALVIEDKM | 821 | Q9Y3R5 | |
| FQKAQAISVLHEMIQ | 71 | P01568 | |
| KILAVQEESSNLMQH | 836 | Q5BJE1 | |
| VLNMLESFVDLQFKH | 2996 | Q5CZC0 | |
| KHRVDFLQLMIDSQN | 266 | P08684 | |
| LKTQQMNNDLEKLTH | 916 | Q3V6T2 | |
| EQIFHLQMKLIEQDL | 501 | Q9NQC1 | |
| NHIFELMQNMLEQLL | 21 | Q96MA6 | |
| KLQQLFNHTMFVLEQ | 501 | Q7Z406 | |
| RMFILQSKEAIHSQL | 66 | O60925 | |
| KLEELQSMKQHLLFQ | 3256 | Q9Y6V0 | |
| QQSVNHLVKEIDMLL | 321 | Q53EL6 | |
| TQLQHKFEQVVALME | 1901 | Q9Y4D7 | |
| LIENHSNTSFEQLKM | 171 | Q96KP1 | |
| IHSMQVLQQVDNKFI | 1186 | Q9UHC1 | |
| DLNLVQNFQMKHEVL | 581 | O76074 | |
| FQKAQAISVLHEMIQ | 71 | P01569 | |
| FQKTQAISVLHEMIQ | 71 | P01567 | |
| IQHPSLMFEQEVKNL | 2201 | Q6KC79 | |
| SRMQVEQNLSDHIKL | 436 | Q9H3R0 | |
| LFRHDMNSENILQLI | 111 | O94806 | |
| MTKDFEPILEQQIHQ | 136 | O95163 | |
| VMAQFKEISLHLNAV | 621 | Q9NX02 | |
| MNKENHSLIAEFILT | 1 | A6NET4 | |
| AAQMHLVLLKEQFSN | 181 | Q8WWQ2 | |
| QLRQTMAKFLQEHLA | 51 | P26440 | |
| KDASINIENMQFIHN | 116 | O95297 | |
| LDNTEFQGKRMHVQL | 131 | Q9BQ04 | |
| QQEHLDLMKQLTLTQ | 716 | Q08378 | |
| KNAQDKIELHLFMLN | 416 | Q6P9F7 | |
| AVAQLEEEKQHLLFM | 126 | Q9H0B6 | |
| QELDSVAMKLLHQVS | 926 | Q5TIA1 | |
| HQTLSVEMDQVLKAL | 1031 | Q5TIA1 | |
| VADLLQHINQMKTAE | 876 | Q92729 | |
| ISNMELELNIHNSKA | 591 | P38398 | |
| QEKEILLEMIHSIQN | 51 | O95816 | |
| FHQQALMELKILEAL | 141 | Q9NR20 | |
| LQAEALQDSLQHLMK | 491 | Q01638 | |
| DEKKLMSFHQNLQDV | 136 | A0AVF1 | |
| HLEQNNFAMKEFIAT | 551 | Q96LB3 | |
| DLIEVQNHIIMFLKA | 76 | A2RU49 | |
| EAKQAEMQLLVVHLS | 111 | Q5T6J7 | |
| IIHDQLEMAFIQKNL | 151 | Q9NZS2 | |
| LDNFVINHMLKNNVA | 26 | P51878 | |
| LFELFTIHLMLQEIQ | 616 | Q96M89 | |
| HQKLSQLQEEFGQLM | 331 | Q6ZP82 | |
| KHLADQMASLELQQV | 521 | Q8NCX0 | |
| NGNFHMFENELITKL | 1141 | Q9H7D0 | |
| MHNVLQAELDKLTSV | 431 | P49454 | |
| QMHFAELQEKFLSLQ | 1401 | P49454 | |
| AHAVEQQMQKLLEET | 136 | Q8IWX8 | |
| NIINMHNVKLFLFQL | 256 | Q00536 | |
| DIFENQLKQKELAHM | 666 | Q8N960 | |
| IKILEMFSAHNLQSV | 1006 | Q6P158 | |
| QALQDVEKAIMVFEH | 546 | O15360 | |
| ASQLLHLNAKEMAFN | 176 | Q8ND61 | |
| EKQDIIISFQHMQQL | 276 | Q6ZRK6 | |
| MAAQENHLEVVKFLL | 146 | Q12955 | |
| KIQIAFSQHNTIMDL | 1216 | Q5VV63 | |
| VFALMVQLKAQELEH | 341 | Q8TD31 | |
| VLIRADHHQQMFNIK | 1941 | Q99698 | |
| LDKIEKQMFQLHIGN | 281 | Q7Z4H7 | |
| ALHQAQMSKEVVELN | 516 | Q2VIQ3 | |
| HSIFLINIKQENMET | 206 | Q12840 | |
| NVKLLSEIEFLVNHM | 266 | Q9NV70 | |
| FQKAQAISVLHEMIQ | 71 | P32881 | |
| KHRVDFLQLMIDSQN | 266 | P24462 | |
| NLEVQNILSFLKMQH | 486 | Q96AC1 | |
| EAHQNVAQMSLIEAK | 541 | Q96AC1 | |
| VFLDLEQHLNELMTK | 546 | O60645 | |
| IQRVEAMFHTLDKIN | 76 | Q13255 | |
| QLELSEMEAFVNQHK | 176 | Q8NFJ9 | |
| LLAQGQFHDLKQLFM | 216 | Q99675 | |
| NEFLLMVILQDKEHT | 201 | Q5T7M9 | |
| QLQDNKTFLAMLNHV | 111 | Q9NTJ5 | |
| IRIMKHENDNAFLAN | 4016 | Q9NZJ4 | |
| EKLNSSLHFLQQEMQ | 896 | Q08AD1 | |
| FQKTQAISVLHEMIQ | 71 | P01571 | |
| EKLQQLFNHTMFILE | 481 | P35580 | |
| MSSLLERLHAKFNQN | 16 | Q15648 | |
| LMHFNTLNNIDVIKE | 696 | P47712 | |
| KDQMELFLQNHVFPL | 451 | O15397 | |
| MVENSIFRAHKNVLA | 51 | Q96JB3 | |
| LIFSLQKHLQKMQLN | 201 | Q9NYV9 | |
| VLMDQSRFHELQLQL | 326 | Q9NUJ3 | |
| EMLIAQNSSLEFKLH | 181 | Q9H871 | |
| FMKAVEILRNNTHLA | 591 | Q8TEU7 | |
| LMIKFQSHRNILEEN | 1136 | Q96R06 | |
| MITLETNIEHNLKSE | 456 | Q9H2G2 | |
| IAFQLHEDLMKVLNE | 146 | Q7Z6B7 | |
| VIVTSFQKANMLDQH | 96 | Q96NR3 | |
| TKEALINHFNLMINK | 256 | Q5K651 | |
| MATQQFESAKRLILH | 371 | A1A5C7 | |
| HKEEVLQELNMFPQL | 101 | Q9NVN8 | |
| INLQDETFLESNKMH | 951 | Q9BQS7 | |
| FDLNEAIMNRHNVIK | 341 | O43166 | |
| HRLVLQSVANMKENF | 711 | Q9UIU6 | |
| AMSQKHLQINQTFEE | 136 | P51692 | |
| NEAFTLAQQHNKMEI | 981 | Q8NEZ3 | |
| ELLAMLVNFANKHQL | 316 | Q53LP3 | |
| FQKAQAISVLHEMIQ | 71 | P05014 | |
| ERVQFHLKNFDMVIV | 846 | Q9Y5B9 | |
| QLLADRQAFHMEQLK | 926 | Q8TAQ2 | |
| LNMDHTVVLQLAEKN | 176 | Q96H20 | |
| ELQIFKHSSIILNME | 496 | O95025 | |
| RNLQDAQKFILMHEV | 371 | Q13591 | |
| QFLKEQRVHLENMGS | 121 | Q01082 | |
| IFQQLAHMVKEQEET | 286 | Q13190 | |
| AMSQKHLQINQTFEE | 136 | P42229 | |
| QTLKEHVQDFAMQLS | 291 | Q9BT49 | |
| MEALIISKFNHQNIV | 1166 | Q9UM73 | |
| AQQLEKHQLMEFRCI | 1496 | P53675 | |
| MNQAAKHFLLQTVEN | 326 | Q14CN2 | |
| EKLQQLFNHTMFILE | 481 | P35749 | |
| MEAKQNLERHISTLN | 1356 | P35749 | |
| QKANDVLLSHMITFL | 571 | Q99570 | |
| VLLSHMITFLNDKND | 576 | Q99570 | |
| QHLKSVMLQIAATEL | 16 | P48788 | |
| LTELHINDNMLKFFN | 666 | Q9NR97 | |
| EFITVHSMLDQQQKQ | 266 | Q8WUH2 | |
| LLQAIHQLDFIQMKC | 496 | Q6ZTA4 | |
| MHIFQTEEKIDNQVV | 151 | Q86XN6 | |
| LQEENKQLMTNLSHK | 126 | Q5EBL4 | |
| SATQNQLLFHMLKEK | 1076 | Q7Z4S6 | |
| NKNFHEVMLALTVLE | 61 | O60784 | |
| NSDQLHMLAEKLTVQ | 511 | Q14765 | |
| MKIEIHFDLQFNISQ | 381 | Q5T4T6 | |
| DVKLLQFHVATMVDN | 306 | P24928 | |
| NSESKVFQLLHKNML | 1391 | Q6ZV73 | |
| LQAMISKEFHLAATQ | 61 | Q9UIG5 | |
| MHVALAQKDQEIAFL | 301 | Q6Q0C0 | |
| QMSALQKNFIETHKL | 1036 | Q8IWV7 | |
| DAKQLNMFLDIIHQN | 91 | Q9HBJ7 | |
| VEQTIAIMKNLLDNH | 961 | P21359 | |
| QRNLLQMTEKFFHAI | 1336 | P21359 | |
| EKQEMFAVHSVNLLL | 3351 | Q709C8 | |
| AKQTLQHFLEQHERM | 346 | Q6NWY9 | |
| QKLHTQELLSQLEMA | 616 | Q96NL6 | |
| QFLKEQRVHLENMGS | 121 | P11277 | |
| ASRLMLQLQHDAFQK | 236 | O43711 | |
| AAIQVFEKMNQTHLS | 71 | Q56P42 | |
| SQAHIQQMDLLGKLF | 256 | Q9H0C1 | |
| DVMNVEKLFVRNHTL | 676 | Q9BY31 | |
| FKVVDLLTMASQHQN | 736 | Q6ZT12 | |
| ASKILDHQQQMTVLD | 1751 | Q9Y4G6 | |
| QAAELFMEQQHLKEA | 716 | Q9ULT0 | |
| NIEQAHEAFKMAQSL | 876 | Q6PGP7 | |
| SLLKNASIQHLQEMD | 781 | Q13395 | |
| KEILMNSQHETEFIL | 1306 | Q9C0G0 | |
| LKEAIENHQNMIKQF | 446 | Q9NV66 | |
| HKLALFNSAIVMQES | 631 | Q6ZXV5 | |
| DHFLIMTDQVKLALN | 2111 | O15050 | |
| NESQHRLDFQLMLKI | 51 | Q8NFY4 | |
| AVQLMKQNIAETLHF | 686 | Q14669 | |
| SVDMFSKVLEHQLLQ | 6 | O14530 | |
| DELKHQVMINQFVLT | 6 | Q8TB05 | |
| LMAISDKDQQLSHLQ | 2971 | Q14789 | |
| EKQGVLHLLQSVNMD | 651 | Q12965 | |
| TQFVEKNNDALHMSL | 591 | Q9UM54 |